Ian Olver
School of Psychology
Faculty of Health and Medical Sciences
Professor Ian Olver AM
Professorial Research Fellow, School of Psychology,
Adjunct Professor, School of Public Health
Trained as a medical oncologist, cancer researcher and bioethicist his current research interests are in psycho-oncology, supportive care in cancer and bioethics. Ian is author of over 330 journal articles and is a regular commentator on cancer issues in Australia and internationally.
Ian was appointed a Member of the Order of Australia (AM) for service to medical oncology as a clinician, researcher, administrator and mentor, and to the community through leadership roles with cancer control organisations.
Ian Olver graduated MB, BS from the University of Melbourne in 1976, was awarded an MD in 1991 and completed a PhD from Monash University in bioethics in 1997. He also holds a Certificate of Ministry (Lay Preaching) form the Adelaide College of Divinity. He is a Fellow of the Royal Australasian College of Physicians (FRACP), its Chapter of Palliative Medicine (FAChPM) and is was an Associate Fellow of the Royal Australian College of Medical Administrators (ARACMA) until 2020. He became a Fellow of the Australian Academy of Health and Medical Science (AAHMS) in 2016.
He trained as a medical oncologist at Peter MacCallum Cancer Institute, the Alfred Hospital, Melbourne and the University of Maryland Cancer Centre in Baltimore. He practised at Peter MaCallum and then at The Royal Adelaide Hospital where he became Clinical Director of the RAH Cancer Centre, and the first Cancer Council SA Professor of Cancer Care at the University of Adelaide and set up tele-oncology links with Darwin, established an oncology clinic in Alice Springs and trained the first medical oncologist for the CMC Hospital in Vellore India. From May 2006 to December 2014 he was appointed CEO, Cancer Council Australia in Sydney and received their Gold Medal in 2104. He held an appointment as Clinical Professor in the Department of Medicine at the University of Sydney.
He returned to SA in 2015 and was Director of the Sansom Institute and then UniSA Cancer Research Institute until 2019. In 2020 he took up his current appointments at University of Adelaide.
He is a past chair of the Medical Oncology Group of Australia (MOGA) and received their Cancer Achievement award in 2008 and served on the Clinical Oncology Society of Australia Council and then Board being awarded the Tom Reeve award for "outstanding contributions to caner care" in 2019. He currently chairs the Sax Institute Board in Sydney and the Youth and Young Adults Advisory Board to Canteen in Sydney.
He currently consults for Bellberry Ethics and Chairs the MOGA Ethics Committee.
He is a past chair of the Australian Health Ethics Committee of NHMRC and sat on NHMRC Council. He is a past President of the Multinational Association of Supportive Care in Cancer.
-
Appointments
Date Position Institution name 2020 - ongoing Professorial Research Fellow University of Adelaide 2020 - ongoing Adjunct Professor University of Adelaide 2018 - ongoing Senior Principal Research Fellow South Australian Health and Medical Research Institute 2018 - 2019 Director University of South Australia 2018 - 2019 Research, Dean of Research Strategy University of South Australia 2015 - 2018 Director Sansom Institute of Health Research 2006 - 2011 Honorary Associate Royal Prince Alfred Hospital 2006 - ongoing Clinical Professor University of Sydney 2006 - ongoing Adjunct Professor University of Adelaide 2006 - ongoing Emeritus appointment Royal Adelaide Hospital 2001 - 2014 Chief Executive Officer Cancer Council Australia -
Awards and Achievements
Date Type Title Institution Name Country Amount 2014 Distinction Gold Medal of Cancer Council Australia for Distinguished Service in Cancer Cancer Council Australia Australia - -
Education
Date Institution name Country Title 1997 Monash University Australia PhD 1991 University of Melbourne Australia Doctorate of Medicine 1986 Monash University Australia Masters 1971 - 1976 University of Melbourne Australia Bachelor of Medicine and Bachelor of Surgery -
Postgraduate Training
Date Title Institution Country 2016 FAHMS Australian Academy of Health and Medical Sciences Australia 2000 FAChPM Australian Chapter Palliative Medicine Australia 1993 - 2020 AFRACMA Royal Australasian College of Medical Administrators Australia 1984 FRACP Royal Australasian College of Physicians Australia
-
Journals
Year Citation 2024 Olver, I., Clark-Snow, R., Ruhlmann, C. H., Garcia-del-Barrio, M. A., Schwartzberg, L., Rapoport, B. L., & Jahn, F. (2024). 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive Care in Cancer, 32(1), 5 pages.
2024 Molassiotis, A., Affronti, M. L., Fleury, M., Olver, I., Giusti, R., & Scotte, F. (2024). 2023 MASCC/ESMO consensus antiemetic guidelines related to integrative and non-pharmacological therapies. Supportive Care in Cancer, 32(1), 8 pages.
2024 Bartram, A., Harrison, N. J., Norris, C. A., Kim, S., Pettigrew, S., Room, R., . . . Bowden, J. A. (2024). Which parents provide zero-alcohol beverages to adolescents? A survey of Australian parents' practices and intentions. Preventive Medicine, 179, 8 pages.
Scopus12024 Yip, R., Arnolda, G., Lamprell, K., Nic Giolla Easpaig, B., Chittajallu, R., Delaney, G., . . . Braithwaite, J. (2024). Experience of patients considering or using checkpoint inhibitors in cancer treatment: A systematic review of qualitative research. Journal for ImmunoTherapy of Cancer, 12(1), 14 pages.
Europe PMC12024 Lewis, S., La Brooy, C., Kerridge, I., Holmes, A., Olver, I., Hudson, P., . . . Komesaroff, P. (2024). Choreographing a good death: Carers’ experiences and practices of enacting assisted dying. Sociology of Health and Illness, 19 pages.
2024 Harrison, N. J., Norris, C. A., Bartram, A., Murphy, M., Pettigrew, S., Dell, A. O., . . . Bowden, J. A. (2024). “They start on the zero-alcohol and they wanna try the real thing”: Parents' views on zero-alcohol beverages and their use by adolescents. Australian and New Zealand Journal of Public Health, 100119.
Scopus12024 Herrstedt, J., Clark-Snow, R., Ruhlmann, C. H., Molassiotis, A., Olver, I., Rapoport, B. L., . . . Scotté, F. (2024). 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. ESMO Open, 9(2), 102195.
Scopus2 Europe PMC32023 De Groef, A., Evenepoel, M., Van Dijck, S., Dams, L., Haenen, V., Wiles, L., . . . Meeus, M. (2023). Feasibility and pilot testing of a personalized eHealth intervention for pain science education and self-management for breast cancer survivors with persistent pain: a mixed-method study. Supportive Care in Cancer, 31(2), 22 pages.
Scopus8 WoS3 Europe PMC72023 Owais, S. S., Arnolda, G., Lamprell, K., Liauw, W., Delaney, G. P., Olver, I., . . . Braithwaite, J. (2023). Age-related experiences of colorectal cancer diagnosis: a secondary analysis of the English National Cancer Patient Experience Survey. BMJ Open Gastroenterology, 10(1), e001066-1-e001066-12.
2023 Semenenko, E., Banerjee, S., Olver, I., & Ashinze, P. (2023). Review of psychological interventions in patients with cancer. Supportive Care in Cancer, 31(4), 10 pages.
Scopus4 WoS4 Europe PMC42023 Treleaven, L., Komesaroff, P., La Brooy, C., Olver, I., Kerridge, I., & Philip, J. (2023). A review of the utility of prognostic tools in predicting 6-month mortality in cancer patients, conducted in the context of voluntary assisted dying. Internal Medicine Journal, 53(12), 2180-2197.
2023 Ahmed, M., Mäkinen, V. -P., Lumsden, A., Boyle, T., Mulugeta, A., Lee, S. H., . . . Hyppönen, E. (2023). Metabolic profile predicts incident cancer: A large-scale population study in the UK Biobank.. Metabolism: clinical and experimental, 138, 1-9.
Scopus5 WoS3 Europe PMC22023 Madakkatel, I., Lumsden, A. L., Mulugeta, A., Olver, I., & Hyppönen, E. (2023). Hypothesis-free discovery of novel cancer predictors using machine learning. European Journal of Clinical Investigation, 53(10), 1-13.
2023 Skaczkowski, G., Barrett, A., Olver, I., Dollman, J., & Gunn, K. M. (2023). ‘It is a life changing experience’: The experiences of living kidney donors who live in rural Australia. Australian Journal of Rural Health, 31(5), 866-877.
2023 Molassiotis, A., Zhao, I. Y., Crichton, M., Olver, I., Fleury, M., Giusti, R., . . . Affronti, M. L. (2023). Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic review. Supportive Care in Cancer, 31(7), 19 pages.
Scopus3 Europe PMC22023 Philip, J., Le, B., La Brooy, C., Olver, I., Kerridge, I., & Komesaroff, P. (2023). Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?. Current Treatment Options in Oncology, 24(10), 1351-1364.
Scopus22023 Philip, J., Le, B., La Brooy, C., Olver, I., Kerridge, I., & Komesaroff, P. (2023). Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years? (Current Treatment Options in Oncology, (2023), 24, 10, (1351-1364), 10.1007/s11864-023-01126-8). Current Treatment Options in Oncology, 24(10), 1365-1366.
2023 van der Kruk, S., Harrison, N. J., Bartram, A., Newton, S., Miller, C., Room, R., . . . Bowden, J. (2023). Prevalence of parental supply of alcohol to minors: a systematic review. Health Promotion International, 38(5), 1-25.
Scopus1 WoS12023 De Groef, A., Meeus, M., Heathcote, L. C., Wiles, L., Catley, M., Vogelzang, A., . . . Moseley, G. L. (2023). Treating persistent pain after breast cancer: practice gaps and future directions. Journal of Cancer Survivorship, 17(6), 1698-1707.
Scopus4 WoS3 Europe PMC12022 Ward, P. R., Foley, K., Meyer, S. B., Wilson, C., Warin, M., Miller, E. R., . . . Lunnay, B. (2022). How does social class shape women's alcohol stockpiling during COVID-19?: A qualitative study in South Australia during the 2020 lockdown. SSM. Qualitative Research in Health, 2, 100080-1-100080-7.
Scopus5 WoS3 Europe PMC22022 Huppatz, E., Lunnay, B., Foley, K., Miller, E., Warin, M., Wilson, C., . . . Ward, P. (2022). Adaptive capacity: A qualitative study of midlife Australian women's
resilience during COVID-19. SSM. Mental Health, 2, 1-8.
Scopus52022 Chittem, M., Eliott, J., & Olver, I. (2022). Demonstrating the importance of cultural considerations at end of life utilizing the perspective of Indian patients with cancer. Supportive Care in Cancer, 30(3), 2515-2525.
Scopus3 WoS1 Europe PMC12022 Li, M., Reintals, M., D'Onise, K., Farshid, G., Holmes, A., Joshi, R., . . . Roder, D. M. (2022). Investigating the breast cancer screening-treatment-mortality pathway of women diagnosed with invasive breast cancer: Results from linked health data.. European journal of cancer care, 31(1), 12 pages.
Scopus2 WoS1 Europe PMC12022 Bandiera, C., Skrabal Ross, X., Cardoso, E., Wagner, D., Csajka, C., Olver, I., . . . Schneider, M. (2022). Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland. Supportive Care in Cancer, 30(5), 3655-3659.
Scopus1 WoS1 Europe PMC12022 Ward, P. R., Foley, K., Meyer, S. B., Wilson, C., Warin, M., Batchelor, S., . . . Lunnay, B. (2022). Place of alcohol in the ‘wellness toolkits’ of midlife women in different social classes: a qualitative study in South Australia. Sociology of Health and Illness, 44(2), 488-507.
Scopus14 WoS8 Europe PMC52022 Skrabal Ross, X., Gunn, K. M., Suppiah, V., Patterson, P., Boyle, T., Carrington, C., . . . Olver, I. (2022). A smartphone program to support adherence to oral chemotherapy in people with cancer: Proof-of-concept trial. Asia-Pacific Journal of Clinical Oncology, 18(5), e378-e387.
2022 Nic Giolla Easpaig, B., Tran, Y., Winata, T., Lamprell, K., Fajardo Pulido, D., Arnolda, G., . . . Braithwaite, J. (2022). The complexities, coordination, culture and capacities that characterise the delivery of oncology services in the common areas of ambulatory settings.. BMC health services research, 22(1), 15 pages.
2022 van der Kruk, S. R., Butow, P., Mesters, I., Boyle, T., Olver, I., White, K., . . . Clinical Oncological Society of Australia. (2022). Psychosocial well-being and supportive care needs of cancer patients and survivors living in rural or regional areas: a systematic review from 2010 to 2021.. Support Care Cancer, 30(2), 1021-1064.
Scopus31 WoS20 Europe PMC142022 Lunnay, B., Nicholls, E., Pennay, A., MacLean, S., Wilson, C., Meyer, S. B., . . . Ward, P. R. (2022). Sober Curiosity: A Qualitative Study Exploring Women’s Preparedness to Reduce Alcohol by Social Class. International Journal of Environmental Research and Public Health, 19(22), 14788.
Scopus4 WoS1 Europe PMC12022 Bierbaum, M., Rapport, F., Arnolda, G., Delaney, G. P., Liauw, W., Olver, I., & Braithwaite, J. (2022). Clinical practice guideline adherence in oncology: A qualitative study of insights from clinicians in Australia. PLoS ONE, 17(12 December), 32 pages.
Scopus5 WoS4 Europe PMC42022 Lunnay, B., Foley, K., Meyer, S. B., Miller, E. R., Warin, M., Wilson, C., . . . Ward, P. R. (2022). 'I have a healthy relationship with alcohol': Australian midlife women, alcohol consumption and social class. Health Promotion International, 37(4), daac097-1-daac097-12.
Scopus10 WoS5 Europe PMC52022 Meyer, S. B., Lunnay, B., Warin, M., Foley, K., Olver, I. N., Wilson, C., . . . Ward, P. R. (2022). Examining social class as it relates to heuristics women use to determine the trustworthiness of information regarding the link between alcohol and breast cancer risk. PLoS One, 17(9), 1-19.
Scopus6 WoS4 Europe PMC32022 Bowden, J., Harrison, N. J., Caruso, J., Room, R., Pettigrew, S., Olver, I., & Miller, C. (2022). Which drinkers have changed their alcohol consumption due to energy content concerns? An Australian survey. BMC Public Health, 22(1), 13 pages.
2021 Holden, C. A., Turnbull, D., Frank, O. R., & Olver, I. (2021). General practice perspectives on a bowel cancer screening quality improvement intervention using the Consolidated Framework for Implementation Research. Public Health Research and Practice, 31(3), 1-9.
Scopus3 WoS1 Europe PMC32021 Ghinea, N., Critchley, C., Morrell, B., Kerridge, I., Campbell, T., Day, R., . . . Lipworth, W. (2021). A survey of Australian public attitudes towards funding of high cost cancer medicines. Health Policy, 125(3), 327-334.
Scopus3 WoS2 Europe PMC22021 Kida, K., Olver, I., Yennu, S., Tripathy, D., & Ueno, N. T. (2021). Optimal Supportive Care for Patients With Metastatic Breast Cancer According to Their Disease Progression Phase.. JCO oncology practice, 17(4), 177-184.
Scopus10 WoS7 Europe PMC52021 Olver, I. N., Chin, M., & Lalla, R. V. (2021). Now we are 30: 10 more years of MASCC.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(4), 1713-1718.
Scopus1 Europe PMC12021 Gunn, K. M., Skrabal Ross, X., McLoughlin, M., McDonald, S., & Olver, I. (2021). The psychosocial experiences and supportive care preferences of organ transplant recipients and their carers who live in regional Australia. Australian Journal of Rural Health, 29(1), 92-105.
Scopus7 WoS4 Europe PMC42021 Skrabal Ross, X., Gunn, K. M., & Olver, I. (2021). Understanding the strategies rural cancer patients and survivors use to manage financial toxicity and the broader implications on their lives.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(9), 10 pages.
Scopus9 WoS8 Europe PMC52021 Sansom-Daly, U. M., Lobb, E. A., Evans, H. E., Breen, L. J., Ugalde, A., Best, M., . . . PoCoG End of Life Care Special Interest Group. (2021). To be mortal is human: professional consensus around the need for more psychology in palliative care. BMJ Supportive and Palliative Care, 11(4), 002884-1-002884-3.
Scopus10 WoS1 Europe PMC42021 Olver, I. (2021). Supportive care practice: do we need guidelines?. Curr Opin Oncol, Publish Ahead of Print(4), 273-278.
2021 Li, M., Roder, D., D'Onise, K., Walters, D., Farshid, G., Buckley, E., . . . Olver, I. (2021). Female breast cancer treatment and survival in South Australia: Results from linked health data.. Eur J Cancer Care (Engl), 30(5), 1-12.
Scopus2 WoS2 Europe PMC22021 Gunn, K. M., Olver, I., Skrabal Ross, X., Harrison, N., Livingston, P. M., & Wilson, C. (2021). Improving Survivors’ Quality of Life Post-Treatment: The Perspectives of Rural Australian Cancer Survivors and Their Carers. Cancers, 13(7), 1600.
Scopus18 WoS13 Europe PMC102021 Kemp, E., Knott, V., Ward, P., Freegard, S., Olver, I., Fallon-Ferguson, J., . . . Koczwara, B. (2021). Barriers to employment of Australian cancer survivors living with geographic or socio-economic disadvantage: a qualitative study. Health expectations : an international journal of public participation in health care and health policy, 24(3), 951-966.
Scopus5 WoS4 Europe PMC22021 Lunnay, B., Foley, K., Meyer, S. B., Warin, M., Wilson, C., Olver, I., . . . Ward, P. R. (2021). Alcohol consumption and perceptions of health risks during COVID-19: a qualitative study of middle-aged women in South Australia. Frontiers in Public Health, 9, 1-11.
Scopus28 WoS18 Europe PMC112021 Beckmann, K., Selva-Nayagam, S., Olver, I., Miller, C., Buckley, E. S., Powell, K., . . . Oehler, M. K. (2021). Carcinosarcomas of the uterus: prognostic factors and impact of adjuvant treatment. Cancer Management and Research, 13, 4633-4645.
Scopus5 WoS4 Europe PMC32021 Miller, E. R., Olver, I. N., Wilson, C. J., Lunnay, B., Meyer, S. B., Foley, K., . . . Ward, P. R. (2021). COVID-19, alcohol consumption and stockpiling practises in midlife women: repeat surveys during lockdown in Australia and the United Kingdom. Frontiers in Public Health, 9, 1-11.
Scopus10 WoS8 Europe PMC62021 Lunnay, B., Toson, B., Wilson, C., Miller, E. R., Meyer, S. B., Olver, I. N., . . . Ward, P. R. (2021). Social class and changes in Australian women's affect and alcohol consumption during COVID-19. Frontiers in Public Health, 9, 645376-1-645376-15.
Scopus14 WoS10 Europe PMC72021 Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., & Bezak, E. (2021). Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose. Head and Neck, 43(10), 3086-3096.
Scopus1 WoS1 Europe PMC12021 Patel, J. N., Olver, I., & Ashbury, F. (2021). Pharmacogenomics in cancer supportive care: key issues and future directions.. Support Care Cancer, 29(11), 6187-6191.
Scopus1 WoS12021 Nic Giolla Easpaig, B., Tran, Y., Winata, T., Lamprell, K., Fajardo Pulido, D., Arnolda, G., . . . Braithwaite, J. (2021). Providing outpatient cancer care for CALD patients: a qualitative study. BMC Research Notes, 14(1), 304-1-304-8.
Scopus2 WoS22021 Gunn, K. M., Luker, J., Ramanathan, R., Skrabal Ross, X., Hutchinson, A., Huynh, E., & Olver, I. (2021). Choosing and Managing Aged Care Services from Afar: What Matters to Australian Long-Distance Care Givers. International Journal of Environmental Research and Public Health, 18(24), 1-17.
Scopus5 WoS5 Europe PMC32021 Ward, P. R., Lunnay, B., Foley, K., Meyer, S. B., Thomas, J., Olver, I., & Millere, E. R. (2021). The Case of Australia. The International Journal of Social Quality, 11(1-2), 289-308.
Scopus72021 Huanhuan, C., Li, M., Wang, M., Roder, D., & Olver, I. (2021). Challenges for ethics committees in biomedical research governance: illustrations from China and Australia. Journal of Medical Ethics and History of Medicine, 14, 1-14.
Scopus4 Europe PMC32020 Olver, I. N., Gunn, K. M., Knott, V. E., Chong, A., Spronk, K., & Cunningham, J. (2020). Communicating cancer and its treatment to Australian Aboriginal patients with cancer: a qualitative study. Supportive Care in Cancer, 38(15), 1-2.
Scopus5 WoS4 Europe PMC22020 Gunn, K. M., Ross, X. S., & Olver, I. (2020). Optimizing Rural People's Access to Relevant Cancer Education and Support Using Peer-Led YouTube Films.. Journal of Cancer Education, 37(4), 10 pages.
Scopus6 WoS4 Europe PMC52020 Martin, J. H., & Olver, I. (2020). Precision medicine-based drug treatment individualization in oncology. British Journal of Clinical Pharmacology, 87(2), 223-226.
Scopus7 WoS6 Europe PMC42020 Bierbaum, M., Rapport, F., Arnolda, G., Nic Giolla Easpaig, B., Lamprell, K., Hutchinson, K., . . . Braithwaite, J. (2020). Clinicians' attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: A systematic review of qualitative and quantitative literature. Implementation Science, 15(1), 24 pages.
Scopus45 WoS32 Europe PMC302020 Polo, T. C. F., Corrente, J. E., Miot, L. D. B., Papini, S. J., & Miot, H. A. (2020). Dietary patterns of patients with psoriasis at a public healthcare institution in Brazil. Anais Brasileiros de Dermatologia, 95(4), 452-458.
Scopus12 WoS6 Europe PMC52020 Holden, C. A., Frank, O., Caruso, J., Turnbull, D., Reed, R. L., Miller, C. L., & Olver, I. (2020). From participation to diagnostic assessment: a systematic scoping review of the role of the primary healthcare sector in the National Bowel Cancer Screening Program.. Aust J Prim Health, 26(3), 191-206.
Scopus3 WoS2 Europe PMC22020 Li, M., Roder, D., D'Onise, K., Walters, D., Farshid, G., Buckley, E., . . . Olver, I. (2020). Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study. BMJ Open, 10(6), e037069.
Scopus4 WoS3 Europe PMC32020 Young, A. M., Ashbury, F. D., Schapira, L., Scotté, F., Ripamonti, C. I., & Olver, I. N. (2020). Uncertainty upon uncertainty: supportive Care for Cancer and COVID-19.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 28(9), 4001-4004.
Scopus53 WoS46 Europe PMC372020 Roder, D., Selva-Nayagam, S., Paramasivam, S., Keefe, D., Olver, I., Miller, C., . . . Oehler, M. (2020). Cancers of the corpus uteri treated in South Australian public hospitals: Trends in clinical management and survival across three decades.. Eur J Cancer Care (Engl), 29(5), 1-12.
2020 Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., . . . Bezak, E. (2020). Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers.. Cells, 9(8), 14 pages.
Scopus7 WoS6 Europe PMC42020 Holden, C. A., Frank, O., Li, M., Manocha, R., Caruso, J., Turnbull, D., . . . Olver, I. (2020). Engagement of General Practice in an Australian Organised Bowel Cancer Screening Program: A Cross-Sectional Survey of Knowledge and Practice.. Asian Pac J Cancer Prev, 21(7), 2099-2107.
Scopus4 Europe PMC22020 Olver, I., Carey, M., Bryant, J., Boyes, A., Evans, T., & Sanson-Fisher, R. (2020). Second opinions in medical oncology. BMC Palliative Care, 19(1), 112-1-112-6.
Scopus11 WoS9 Europe PMC82020 Grimison, P., Mersiades, A., Kirby, A., Lintzeris, N., Morton, R., Haber, P., . . . Stockler, M. (2020). Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV): a randomised, placebo-controlled, phase 2 crossover trial.. Ann Oncol, 31(11), 1553-1560.
Scopus70 WoS51 Europe PMC442020 Olver, I. N. (2020). Prostate cancer treatment in private and public health services.. Med J Aust, 213(9), 408-409.
2020 Whitford, H. S., Kalinowski, P., Schembri, A., Grimison, P., Stockler, M., Martin, A., . . . Australian and New Zealand Urogenital and Prostate Cancer Trials Group. (2020). The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer. Supportive Care in Cancer, 28(7), 3081-3091.
Scopus12 WoS12 Europe PMC92020 Nic Giolla Easpaig, B., Tran, Y., Bierbaum, M., Arnolda, G., Delaney, G. P., Liauw, W., . . . Braithwaite, J. (2020). What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence. BMC Health Services Research, 20(1), 102-1-102-24.
Scopus51 WoS44 Europe PMC352020 Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., & Bezak, E. (2020). Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers. Scientific Reports, 10(1), 8 pages.
Scopus9 WoS7 Europe PMC62020 Ngwa, W., Olver, I., & Schmeler, K. M. (2020). The Use of Health-Related Technology to Reduce the Gap Between Developed and Undeveloped Regions Around the Globe.. Am Soc Clin Oncol Educ Book, 40(40), 1-10.
Europe PMC122020 Skrabal Ross, X., Gunn, K. M., Suppiah, V., Patterson, P., & Olver, I. (2020). A review of factors influencing non-adherence to oral antineoplastic drugs. Support Care Cancer, 28(9), 4043-4050.
Scopus19 WoS17 Europe PMC82020 Olver, I., Keefe, D., Herrstedt, J., Warr, D., Roila, F., & Ripamonti, C. I. (2020). Supportive care in cancer-a MASCC perspective.. Support Care Cancer, 28(8), 3467-3475.
Scopus47 WoS36 Europe PMC212020 Ghinea, N., Wiersma, M., Kerridge, I., Olver, I., Pearson, S., Day, R., . . . Lipworth, W. (2020). "Some sort of fantasy land": a qualitative investigation of appropriate prescribing in cancer care. Journal of Evaluation in Clinical Practice, 26(3), 747-754.
Scopus1 WoS1 Europe PMC12019 Roder, D., Karapetis, C. S., Olver, I., Keefe, D., Padbury, R., Moore, J., . . . Price, T. (2019). Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival.. BMJ open, 9(9), 1-11.
Scopus24 WoS16 Europe PMC142019 Nic Giolla Easpaig, B., Arnolda, G., Tran, Y., Bierbaum, M., Lamprell, K., Delaney, G. P., . . . Braithwaite, J. (2019). What is multidisciplinary cancer care like in practice? A protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sector. BMJ Open, 9(10), e031179-1-e031179-10.
Scopus3 WoS3 Europe PMC32019 Olver, I. (2019). Now We Are 40 – 10 More Years of MOGA. Asia-Pacific Journal of Clinical Oncology, 15(S5), 8-16.
2019 Li, M., Olver, I., Keefe, D., Holden, C., Worthley, D., Price, T., . . . Roder, D. (2019). Pre-diagnostic colonoscopies reduce cancer mortality - Results from linked population-based data in South Australia. BMC Cancer, 19(1), 856.
Scopus9 WoS4 Europe PMC12019 Heathcote, L. C., Allen, J. M., Gunn, K. M., Fox, S., Harvie, D. S., Olver, I., . . . Moseley, G. L. (2019). Pain Education for Adolescents and Young Adults Living Beyond Cancer: An Interdisciplinary Meeting Report. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 8(5), 5 pages.
Scopus6 WoS9 Europe PMC32019 Hall, A., Nguyen, S. M., Mackenzie, L., Sanson-Fisher, R., Olver, I., Thuan, T. V., & Huong, T. T. (2019). What Caused My Cancer? Cancer Patients’ Perceptions on What May Have Contributed to the Development of Their Cancer: A Cross-Sectional, Cross-Country Comparison Study. Cancer Control, 26(1), 10 pages.
Scopus6 WoS4 Europe PMC62019 Skrabal Ross, X., Gunn, K. M., Olver, I., Willems, R. A., Lechner, L., Mesters, I., & Bolman, C. A. W. (2019). Online psychosocial interventions for posttreatment cancer survivors: an international evidence review and update.. Curr Opin Support Palliat Care, 14(1), 40-50.
Scopus24 WoS11 Europe PMC142019 Willems, R. A., Bolman, C. A. W., Lechner, L., Mesters, I., Gunn, K. M., Ross, X. S., & Olver, I. (2019). Online interventions aimed at reducing psychological distress in cancer patients: evidence update and suggestions for future directions.. Current opinion in supportive and palliative care, 14(1), 27-39.
Scopus22 WoS15 Europe PMC142019 Ross, X. S., Gunn, K. M., Patterson, P., & Olver, I. (2019). Development of a smartphone program to support adherence to oral chemotherapy in people with cancer. Patient Preference and Adherence, 13, 2207-2215.
Scopus6 WoS4 Europe PMC12019 Olver, I., Dodds, S., Kenner, J., Kerridge, I., McGovern, K., Milligan, E., & Mortimer, R. (2019). Ethical considerations relating to healthcare resource allocation decisions. Internal medicine journal, 49(11), 1364-1367.
Scopus5 WoS5 Europe PMC12019 Meyer, S. B., Foley, K., Olver, I., Ward, P. R., McNaughton, D., Mwanri, L., & Miller, E. R. (2019). Alcohol and breast cancer risk: Middle-aged women's logic and recommendations for reducing consumption in Australia. PLoS ONE, 14(2), 20 pages.
Scopus24 WoS19 Europe PMC122019 Reid, P., Marcu, L. G., Olver, I., Moghaddasi, L., Staudacher, A. H., & Bezak, E. (2019). Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Radiotherapy and Oncology, 135, 1-12.
Scopus22 WoS19 Europe PMC152019 Olver, I. (2019). Aspirin for the prevention of colorectal cancer. Medicine Today, 20(3), 56-59. 2019 Mersiades, A. J., Stockler, M. R., Olver, I. N., & Grimison, P. (2019). Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence. Medical Journal of Australia, 210(1), 11-12.e1.
Scopus3 WoS3 Europe PMC22019 Fennell, K. M., Bamford, L., Olver, I., & Wilson, C. J. (2019). Good training, systems and funding, not good luck: what hematologists and oncologists believe would make it easier for them to refer their cancer patients to psychosocial care.. Translational behavioral medicine, 9(1), 139-146.
Scopus7 WoS6 Europe PMC32018 Karapetis, C. S., Stein, B., Koczwara, B., Harrup, R., Milleshkin, L., Parente, P., . . . Olver, I. (2018). Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying. Internal Medicine Journal, 48(7), 774-779.
Scopus21 WoS23 Europe PMC62018 Roder, D., Davy, M., Selva-Nayagam, S., Paramasivam, S., Adams, J., Keefe, D., . . . Oehler, M. (2018). Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival. BMC Cancer, 18(1), 10 pages.
Scopus5 WoS5 Europe PMC22018 Olver, I., Carey, M., Boyes, A., Hall, A., Noble, N., Bryant, J., . . . Sanson-Fisher, R. (2018). The timeliness of patients reporting the side effects of chemotherapy. Supportive Care in Cancer, 26(10), 3579-3586.
Scopus18 WoS16 Europe PMC82018 Brooks, D., Olver, I. N., & Esterman, A. J. (2018). Beyond PSA testing for prostate cancer. Medical Journal of Australia, 208(10), 424-426.
Scopus1 WoS2 Europe PMC12018 Dhillon, V. S., Yeoh, E., Salisbury, C., Butters, J., Di Matteo, A., Olver, I., & Fenech, M. (2018). Cytokinesis Block Micronucleus Cytome (CBMN Cyt) Assay Biomarkers and Their Association With Radiation Sensitivity Phenotype in Prostate Cancer Cases and DNA Repair Gene hOGG1 (C1245G) Polymorphism. Environmental and Molecular Mutagenesis, 59(9), 813-821.
Scopus7 WoS7 Europe PMC22018 Olver, I. N. (2018). Improved relative survival of patients with B-cell non-Hodgkin lymphoma in Queensland, 1993-2012. Medical Journal of Australia, 209(4), 157-158.
Scopus1 WoS12018 Mersiades, A. J., Tognela, A., Haber, P. S., Stockler, M., Lintzeris, N., Simes, J., . . . Grimison, P. (2018). Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV). BMJ open, 8(9), e020745.
Scopus15 WoS13 Europe PMC112018 Takhar, H., Singhal, N., Mislang, A., Kumar, R., Kim, L., Selva-Nayagam, S., . . . Brown, M. (2018). Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer. Asia-Pacific Journal of Clinical Oncology, 14(1), 91-100.
Scopus8 WoS8 Europe PMC32018 Smith, A., Rutherford, C., Butow, P., Olver, I., Luckett, T., Grimison, P., . . . King, M. (2018). A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors. Psycho-Oncology, 27(4), 1129-1137.
Scopus47 WoS40 Europe PMC292018 Olver, I., Shi, Q., Qiao, M., Liu, Y., Pan-Hammarstrom, Q., Wang, J., . . . Lu, Z. -X. (2018). The 150 most important questions in cancer research and clinical oncology series: questions 86-93 abstracts. CANCER COMMUNICATIONS, 37(1), 7 pages.
2018 Wilson, C., Flight, I., Zajac, I. T., Turnbull, D., Young, G. P., & Olver, I. (2018). Web-based communication strategies designed to improve intention to minimize risk for colorectal cancer: Randomized controlled trial. JMIR Cancer, 4(1), e2.1-e2.11.
Scopus2 WoS2 Europe PMC12018 Carey, M., Sanson-Fisher, R., Clinton-McHarg, T., Boyes, A., Olver, I., Oldmeadow, C., . . . Henskens, F. (2018). Examining variation across treatment clinics in cancer patients' psychological outcomes: results of a cross sectional survey. Supportive Care in Cancer, 26(9), 3201-3208.
Scopus4 WoS4 Europe PMC22018 Olver, I. (2018). Bowel cancer screening for women at midlife. Climacteric, 21(3), 243-248.
2018 Ross, X. S., Gunn, K. M., Patterson, P., & Olver, I. (2018). Mobile-based oral chemotherapy adherence–enhancing interventions: Scoping review. JMIR mHealth and uHealth, 6(12), 11 pages.
Scopus13 WoS12 Europe PMC92018 Skrabal Ross, X., Gunn, K. M., Patterson, P., & Olver, I. (2018). Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review (Preprint).
2018 Mersiades, A. J., Stockler, M. R., Olver, I. N., & Grimison, P. (2018). Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence.. The Medical journal of Australia. 2017 Wilson, C., Flight, I., Zajac, I. T., Turnbull, D., Young, G. P., & Olver, I. (2017). Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial (Preprint).
2017 Wilson, C., Flight, I., Zajac, I. T., Turnbull, D., Young, G. P., & Olver, I. (2017). Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial.
2017 Olver, I. N. (2017). Rolapitant in the treatment of nausea and vomiting associated with chemotherapy. Clinical Medicine Insights: Therapeutics, 9, 1179559X1771910.
WoS12017 Carey, M., Boyes, A., Smits, R., Bryant, J., Waller, A., & Olver, I. (2017). Access to clinical trials among oncology patients: results of a cross sectional survey. BMC Cancer, 17(1), 1-8.
Scopus16 WoS12 Europe PMC82017 Olver, I. (2017). Cancer control-A global perspective. European Journal of Cancer Care, 26(1), 6 pages.
Scopus8 WoS6 Europe PMC52017 Tattersall, M. H. N., Jefford, M., Martin, A., Olver, I., Thompson, J. F., Brown, R. F., & Butow, P. N. (2017). Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials. BMJ Open, 7(3), 1-7.
Scopus8 WoS7 Europe PMC42017 So, B., Marcu, L. G., Olver, I., Gowda, R., & Bezak, E. (2017). Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas. Acta Oncologica, 56(7), 899-908.
Scopus2 WoS2 Europe PMC22017 So, B., Marcu, L., Olver, I., Gowda, R., & Bezak, E. (2017). Oesophageal cancer: Which treatment is the easiest to swallow? A review of combined modality treatments for resectable carcinomas. Critical Reviews in Oncology/Hematology, 113, 135-150.
Scopus9 WoS8 Europe PMC52017 Lee, Y. C., Kroon, R., Koczwara, B., Haines, I., Francis, K., Millward, M., . . . Mileshkin, L. (2017). Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia. Internal Medicine Journal, 47(8), 888-893.
Scopus4 WoS4 Europe PMC22017 Heiniger, L. E., Smith, A. B., Olver, I., Grimison, P., Klein, B., Wootten, A., . . . Butow, P. N. (2017). e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer. European Journal of Cancer Care, 26(6), 10 pages.
Scopus20 WoS17 Europe PMC122017 Olver, I. N., & Roder, D. (2017). History, development and future of cancer screening in Australia. Public Health Research and Practice, 27(3), 7 pages.
Scopus17 WoS14 Europe PMC92017 Williams, J., Lipworth, W., Mayes, C., Olver, I., & Kerridge, I. (2017). Should disclosure of conflicts of interest in medicine be made public? Medical students’ views. Medical Education, 51(12), 1232-1240.
Scopus1 WoS1 Europe PMC12017 Fennell, K. M., Turnbull, D. A., Bidargaddi, N., Mcwha, J. L., Davies, M., & Olver, I. (2017). The consumer-driven development and acceptability testing of a website designed to connect rural cancer patients and their families, carers and health professionals with appropriate information and psychosocial support. European Journal of Cancer Care, 26(5), 1-15.
Scopus25 WoS21 Europe PMC132017 Olver, I., Ruhlmann, C. H., Jahn, F., Schwartzberg, L., Rapoport, B., Rittenberg, C. N., & Clark-Snow, R. (2017). 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive Care in Cancer, 25(1), 297-301.
Scopus9 WoS3 Europe PMC82017 Dupuis, L. L., Roscoe, J. A., Olver, I., Aapro, M., & Molassiotis, A. (2017). 2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy. Supportive Care in Cancer, 25(1), 317-321.
Scopus26 WoS19 Europe PMC172016 Olver, I. (2016). The importance of supportive care for patients with cancer: supportive care encompasses managing symptoms and side effects before, during and after cancer treatment. Medical Journal of Australia, 204(11), 401-402.e1.
Scopus3 Europe PMC22016 Olver, I. N. (2016). Ethical issues with xenotransplantation clinical trials. Medical Journal of Australia, 204(6), 212.
Scopus5 WoS5 Europe PMC52016 Best, M., Butow, P., & Olver, I. (2016). Palliative care specialists’ beliefs about spiritual care. Supportive Care in Cancer, 24(8), 3295-3306.
Scopus32 WoS23 Europe PMC112016 Olver, I. (2016). Should clinical trials be approached differently for rare cancers?. Future Oncology, 12(10), 1207-1209.
Scopus1 WoS2 Europe PMC12016 Mayes, C., Blakely, B., Kerridge, I., Komesaroff, P., Olver, I., & Lipworth, W. (2016). On the fragility of medical virtue in a neoliberal context: the case of commercial conflicts of interest in reproductive medicine. Theoretical Medicine and Bioethics, 37(1), 97-111.
Scopus5 WoS42016 Miller, E., Ramsey, I., Baratiny, G., & Olver, I. (2016). Message on a bottle: are alcohol warning labels about cancer appropriate?. BMC Public Health, 16(1), 1-10.
Scopus32 WoS33 Europe PMC182016 Olver, I. (2016). Prevention of breast cancer. Medical Journal of Australia, 205(10), 475-479.
Scopus13 WoS8 Europe PMC92016 Olver, I. (2016). New initiatives in the treatment of breast cancer. The Medical journal of Australia, 205(10), 449-450.
Scopus4 WoS2 Europe PMC42016 Roila, F., Molassiotis, A., Herrstedt, J., Aapro, M., Gralla, R., Bruera, E., . . . on, B. O. T. P. O. T. M. C. C. C. (2016). 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy- induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Annals of Oncology, 27(suppl. 5), v119-v133.
Scopus440 WoS364 Europe PMC2552016 Best, M., Butow, P., & Olver, I. (2016). Why do We Find It so Hard to Discuss Spirituality? A Qualitative Exploration of Attitudinal Barriers. JOURNAL OF CLINICAL MEDICINE, 5(9), 10 pages.
Scopus39 WoS35 Europe PMC152016 Olver, I., & Eliott, J. (2016). Translating into practice cancer patients’ views on do-not-resuscitate decision-making. Cancers, 8(10), 89.
Scopus4 WoS3 Europe PMC22016 Best, M., Butow, P., & Olver, I. (2016). Doctors discussing religion and spirituality: A systematic literature review. Palliative Medicine, 30(4), 327-337.
Scopus136 WoS117 Europe PMC622016 Smith, A. B., Butow, P., Olver, I., Luckett, T., Grimison, P., Toner, G. C., . . . King, M. T. (2016). The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study. Journal of Cancer Survivorship, 10(2), 223-233.
Scopus56 WoS49 Europe PMC352016 Olver, I., von Dincklage, J., Nicholson, J., & Shaw, T. (2016). Improving uptake of wiki-based guidelines with Qstream education. Medical Education, 50(5), 590-591.
Scopus3 WoS3 Europe PMC22016 Best, M., Butow, P., & Olver, I. (2016). Creating a safe space: a qualitative inquiry into the way doctors discuss spirituality. Palliative and Supportive Care, 14(5), 519-531.
Scopus30 WoS22 Europe PMC122016 Miller, E., Ramsey, I., Tran, L., Tsourtos, G., Baratiny, G., Manocha, R., & Olver, I. (2016). How Australian general practitioners engage in discussions about alcohol with their patients: a cross-sectional study. BMJ Open, 6(12), e013921-1-e013921-10.
Scopus13 WoS10 Europe PMC42016 Olver, I. (2016). Ethics and cancer. Cancer Forum, 40(2), 95-97.
Scopus1 WoS12016 Koczwara, B., Gordon, L., & Olver, I. (2016). Financial toxicity in clinical care today: a "menu without prices". The Medical journal of Australia, 205(11), 529.
Scopus1 WoS22016 Olver, I. N. (2016). The importance of supportive care for patients with cancer. MEDICAL JOURNAL OF AUSTRALIA, 204(11), 401-+.
WoS32015 Olver, I. N. (2015). The whole 9 years. MEDICAL JOURNAL OF AUSTRALIA, 202(8), 450-+.
2015 Olver, I. N. (2015). Reassessing rare cancers. MEDICAL JOURNAL OF AUSTRALIA, 203(10), 1-+.
2015 Olver, I. N., & Whitford, H. S. (2015). THE IMPACT OF HOPE ON PHYSICAL AND MENTAL HEALTH RESILIENCE IN ONCOLOGY: FINDINGS FROM THE 20/20 VISION FOR CANCER PROJECT. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 11, 61. 2015 Best, M., Aldridge, L., Butow, P., Olver, I., Price, M., & Webster, F. (2015). Treatment of holistic suffering in cancer: A systematic literature review. Palliative Medicine, 29(10), 885-898.
Scopus21 WoS15 Europe PMC72015 Best, M., Aldridge, L., Butow, P., Olver, I., Price, M., & Webster, F. (2015). Assessment of spiritual suffering in the cancer context: A systematic literature review. Palliative & Supportive Care, 13(5), 1335-1361.
Scopus43 WoS36 Europe PMC102015 Olver, I. (2015). Highlights of PSA testing guidelines. Cancer Forum, 39(3), 161-163.
Scopus2 WoS22015 Olver, I., & Marshall, V. (2015). Across the spectrum of prostate cancer. Cancer Forum, 39(3), 159-161. 2015 Best, M., Butow, P., & Olver, I. (2015). Do patients want doctors to talk about spirituality? A systematic literature review. Patient Education and Counseling, 98(11), 1320-1328.
Scopus161 WoS129 Europe PMC892015 Olver, I. N. (2015). The whole 9 years. Medical Journal of Australia, 202(8), 450-452.
2015 Olver, I. N. (2015). Reassessing rare cancers. Medical Journal of Australia, 203(10), 386-1-386-1.e1.
Scopus1 WoS1 Europe PMC12015 Carrera, P., & Olver, I. (2015). The financial hazard of personalized medicine and supportive care. Supportive Care in Cancer, 23(12), 3399-3401.
Scopus23 WoS20 Europe PMC132015 Olver, I. (2015). Role of rolapitant in chemotherapy-induced emesis. The Lancet Oncology, 16(9), 1006-1007.
Scopus8 WoS6 Europe PMC32015 Louise, J., Eliott, J., Olver, I., & Braunack-Mayer, A. (2015). Mandatory cancer risk warnings on alcoholic beverages: what are the ethical issues?. The American Journal of Bioethics, 15(3), 3-11.
Scopus18 WoS18 Europe PMC122015 Whiteman, D., Appleyard, M., Bahin, F., Bobryshev, Y., Bourke, M., Brown, I., . . . Yusoff, I. (2015). Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. Journal of Gastroenterology and Hepatology (Australia), 30(5), 804-820.
Scopus94 WoS79 Europe PMC522015 Lovell, M., Luckett, T., Boyle, F., Stubbs, J., Phillips, J., Davidson, P., . . . Agar, M. (2015). Adaptation of international guidelines on assessment and management of cancer pain for the Australian context. Asia-Pacific Journal of Clinical Oncology, 11(2), 170-177.
Scopus13 WoS10 Europe PMC82015 Best, M., Aldridge, L., Butow, P., Olver, I., & Webster, F. (2015). Conceptual analysis of suffering in cancer: a systematic review. Psycho-Oncology, 24(9), 977-986.
Scopus51 WoS42 Europe PMC242015 Neuhaus, S., Thomas, D., Desai, J., Vuletich, C., Von Dincklage, J., & Olver, I. (2015). Wiki-based clinical practice guidelines for the management of adult onset sarcoma: A new paradigm in sarcoma evidence. Sarcoma, 2015, 614179.
Scopus12 Europe PMC92015 Olver, I. (2015). Assessing the burden and management of chemotherapy induced emesis in the Asia/Pacific region. Supportive Care in Cancer, 23(1), 251-252.
Scopus3 WoS3 Europe PMC22014 Grogan, P. B., & Olver, I. N. (2014). A bowel cancer screening plan at last. Medical Journal of Australia, 201(8), 435-436.
Scopus9 WoS8 Europe PMC62014 Braun, L., Harris, J., Katris, P., Cain, M., Dhillon, H., Koczwara, B., . . . Robotin, M. (2014). Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients. Asia-Pacific Journal of Clinical Oncology, 10(4), 289-296.
Scopus21 WoS18 Europe PMC122014 Best, M., Butow, P., & Olver, I. (2014). The doctor's role in helping dying patients with cancer achieve peace: a qualitative study. Palliative Medicine, 28(9), 1139-1145.
Scopus27 WoS21 Europe PMC122014 Olver, I. N. (2014). Linking data to improve health outcomes: routinely collected data, when linked, are a rich source of sound evidence for making health care decisions. Medical Journal of Australia, 200(7), 368-369.
Scopus20 WoS20 Europe PMC112014 Olver, I. N. (2014). Opting in for opt-out consent. Medical Journal of Australia, 200(4), 201-202.
Scopus11 WoS11 Europe PMC62014 Best, M., Butow, P., & Olver, I. (2014). Spiritual support of cancer patients and the role of the doctor. Supportive Care in Cancer, 22(5), 1333-1339.
Scopus43 WoS43 Europe PMC282014 Whitford, H. S., Jones, S. B. W., & Olver, I. N. (2014). Psychometric properties of the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being, Expanded. QUALITY OF LIFE RESEARCH, 23, 40-41. 2014 Whitford, H., & Olver, I. (2014). Convergent Validity of the Newly Proposed Four-Component Structure of the Functional Assessment of Chronic Illness - Spiritual Well-Being, Expanded. PSYCHO-ONCOLOGY, 23, 368-369. 2014 Klafke, N., Eliott, J., Olver, I., & Wittert, G. (2014). Australian men with cancer practice complementary therapies (CTs) as a coping strategy. Psycho-Oncology, 23(11), 1236-1242.
Scopus12 WoS9 Europe PMC72014 Klafke, N., Eliott, J., Olver, I., & Wittert, G. (2014). The varied contribution of significant others to Complementary and Alternative Medicine (CAM) uptake by men with cancer: a qualitative analysis. European Journal of Oncology Nursing (EJON), 18(3), 329-336.
Scopus7 WoS6 Europe PMC32014 Olver, I., Eliott, J., & Koczwara, B. (2014). A qualitative study investigating chemotherapy-induced nausea as a symptom cluster. Supportive Care in Cancer, 22(10), 2749-2756.
Scopus39 WoS33 Europe PMC222014 O'Carrigan, B., Fournier, M., Olver, I., Stockler, M., Whitford, H., Toner, G., . . . Australian and New Zealand Urogenital and Prostate Cancer Trials Group. (2014). Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study. Internal Medicine Journal, 44(8), 813-817.
Scopus13 WoS11 Europe PMC82014 Klafke, N., Eliott, J., Olver, I., & Wittert, G. (2014). The role of complementary and alternative medicine (CAM) routines and rituals in men with cancer and their significant others (SOs): a qualitative investigation. Supportive Care in Cancer, 22(5), 1319-1331.
Scopus11 WoS9 Europe PMC92014 Olver, I. N. (2014). Linking data to improve health outcomes.. Med J Aust, 200(7), 368-369.
2013 Olver, I. N. (2013). Lung cancer: let's try for prevention and cure.. Med J Aust, 199(10), 639-640.
2013 Olver, I. (2013). Challenges of accessing cancer medicines in Australia. The Lancet Oncology, 14(11), 1040-1042.
Scopus2 WoS2 Europe PMC22013 Ramondetta, L., Sun, C., Surbone, A., Olver, I., Ripamonti, C., Konishi, T., . . . Johnson, J. (2013). Surprising results regarding MASCC members' beliefs about spiritual care. Supportive Care in Cancer, 21(11), 2991-2998.
Scopus33 WoS29 Europe PMC212013 Thaker, D., Monypenny, R., Olver, I., & Sabesan, S. (2013). Cost savings from a telemedicine model of care in northern Queensland, Australia. Medical Journal of Australia, 199(6), 414-417.
Scopus105 WoS94 Europe PMC682013 Smith, A., King, M., Butow, P., & Olver, I. (2013). A comparison of data quality and practicality of online versus postal questionnaires in a sample of testicular cancer survivors. Psycho-Oncology, 22(1), 233-237.
Scopus30 WoS28 Europe PMC182013 Smith, A., King, M., Butow, P., Luckett, T., Grimison, P., Toner, G., . . . Olver, I. (2013). The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study. Psycho-Oncology, 22(11), 2557-2564.
Scopus59 WoS58 Europe PMC432013 Olver, I., & Grogan, P. (2013). Early success for Australia's bowel screening program: let's move it along. Medical Journal of Australia, 198(6), 300-301.
Scopus5 WoS4 Europe PMC22013 Olver, I., & Keech, A. (2013). Forming networks for research: proposal for an Australian clinical trials alliance. Medical Journal of Australia, 198(5), 254-255.
Scopus4 WoS2 Europe PMC22013 Gunn, K., Turnbull, D., McWha, J., Davies, M., & Olver, I. (2013). Psychosocial service use: a qualitative exploration from the perspective of rural Australian cancer patients. Supportive Care in Cancer, 21(9), 2547-2555.
Scopus43 WoS42 Europe PMC242013 Eliott, J., & Olver, I. (2013). Public perceptions of cancer clusters, associated events, and appropriate institutional response. Cancer Forum, 37(1), 93-99. 2013 Goldsbury, D., Harris, M., Pascoe, S., Barton, M., Olver, I., Spigelman, A., . . . O'Connell, D. (2013). The varying role of the GP in the pathway between colonoscopy and surgery for colorectal cancer: a retrospective cohort study. BMJ Open, 3(3), 1-11.
Scopus3 WoS4 Europe PMC12013 Pirri, C., Bayliss, E., Trotter, J., Olver, I., Katris, P., Drummond, P., & Bennett, R. (2013). Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Supportive Care in Cancer, 21(3), 735-748.
Scopus59 WoS51 Europe PMC392013 Olver, I., Grimison, P., Chatfield, M., Stockler, M., Toner, G., Gebski, V., . . . Thomson, D. (2013). Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy. Supportive Care in Cancer, 21(6), 1561-1568.
Scopus25 WoS26 Europe PMC152013 Olver, I. N. (2013). Lung cancer: let's try for prevention and cure. Medical Journal of Australia, 199(10), 639-640.
2013 Olver, I. N., & von Dincklage, J. J. (2013). It is time for clinical guidelines to enter the digital age. Medical Journal of Australia, 199(9), 569-570.
Scopus7 WoS4 Europe PMC62013 Smith, A. B., King, M., Butow, P., Grimison, P., & Olver, I. (2013). Reduced quality of life in internet-panel controls. Epidemiology, 24(3), 462-463.
Scopus3 WoS2 Europe PMC22012 Olver, I. N. (2012). Hormone replacement therapy: The need to combine clinical and epidemiological data. Cancer Forum, 36(3), 167-170. 2012 Goldsbury, D., Harris, M., Pascoe, S., Olver, I., Barton, M., Spigelman, A., & O'Connell, D. (2012). Socio-demographic and other patient characteristics associated with time between colonoscopy and surgery, and choice of treatment centre for colorectal cancer: A retrospective cohort study. BMJ Open, 2(3), 1-11.
Scopus12 WoS12 Europe PMC52012 Olver, I. N. (2012). Evolving definitions of hope in oncology. Current Opinion in Supportive and Palliative Care, 6(2), 236-241.
Scopus27 WoS21 Europe PMC192012 Roder, D. M., & Olver, I. N. (2012). Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?. Medical Journal of Australia, 196(1), 16.
Scopus9 WoS9 Europe PMC52012 Olver, I. N. (2012). Women and tobacco: Part of the bigger picture. Tobacco Control, 21(2), 243-244.
2012 Olver, I. N., & Young, G. P. (2012). The urgency of saving lives through bowel cancer screening. Medical Journal of Australia, 196(8), 490-491.
Scopus3 WoS3 Europe PMC22012 Olver, I., Eliott, J., Long, L., McKinnon, M., & Rumsby, G. (2012). The impact of receiving treatment for cancer at a large metropolitan teaching hospital as recorded by patients using unstructured journals. Journal of Cancer Education, 27(4), 625-630.
Scopus3 WoS3 Europe PMC22012 Whitford, H., & Olver, I. (2012). When expectations predict experience: The influence of psychological factors on chemotherapy toxicities. Journal of Pain and Symptom Management, 43(6), 1036-1050.
Scopus27 WoS24 Europe PMC162012 Olver, I., & Dutney, A. (2012). A randomized, blinded study of the impact of intercessory prayer on spiritual well-being in patients with cancer. Alternative Therapies in Health and Medicine, 18(5), 18-27.
Scopus31 WoS24 Europe PMC102012 Isaac, R., Finkel, M., Olver, I., Annie, I., Prashanth, H., Subhashini, J., . . . Trevena, L. (2012). Translating evidence into practice in low resource settings: cervical cancer screening tests are only part of the solution in rural India. Asian Pacific Journal of Cancer Prevention, 13(8), 4169-4172.
Scopus16 WoS17 Europe PMC82012 Whitford, H., & Olver, I. (2012). The multidimensionality of spiritual wellbeing: peace, meaning, and faith and their association with quality of life and coping in oncology. Psycho-Oncology, 21(6), 602-610.
Scopus111 WoS102 Europe PMC622012 Knott, V., Turnbull, D., Olver, I., & Winefield, A. (2012). A grounded theory approach to understand the cancer-coping process. British Journal of Health Psychology, 17(3), 551-564.
Scopus18 WoS17 Europe PMC82012 Klafke, N., Eliott, J., Wittert, G., & Olver, I. (2012). Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services. Annals of Oncology, 23(6), 1571-1578.
Scopus61 WoS59 Europe PMC422012 Gunn, K., Turnbull, D., Mcwha, L., Davies, M., Bidargaddi, N., & Olver, I. (2012). CONNECTING RURAL CANCER PATIENTS AND THEIR FAMILIES AND CARERS WITH PSYCHOSOCIAL SUPPORT: THE DEVELOPMENT OF A WEBSITE USING A PARTICIPATORY ACTION RESEARCH FRAMEWORK AND BEHAVIOURAL CHANGE THEORY. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 19, S196. 2012 Olver, I. (2012). Human Radiation Injury, 1st Edition. CANCER FORUM, 36(2), 117-118. 2011 Tan, H., Wilson, A., Olver, I., & Barton, C. (2011). The family meeting addressing spiritual and psychosocial needs in a palliative care setting: Usefulness and challenges to implementation. Progress in Palliative Care, 19(2), 66-72.
Scopus3 WoS32011 Whitford, H., & Olver, I. (2011). Prayer as a complementary therapy. Cancer Forum, 35(1), 27-30.
Scopus5 WoS32011 Eliott, J., & Olver, I. (2011). Dying cancer patients talk about physician and patient role in DNR decision making. Health Expectations, 14(2), 147-158.
Scopus12 WoS11 Europe PMC72011 Tan, H., Wilson, A., Olver, I., & Barton, C. (2011). The experience of palliative patients and their families of a family meeting utilised as an instrument for spiritual and psychosocial care: A qualitative study. BMC Palliative Care, 10(1), 7:1-7:12.
Scopus22 WoS24 Europe PMC92011 Garvey, G., Cunningham, J., Valery, P., Condon, J., Roder, D., Bailie, R., . . . Olver, I. (2011). Reducing the burden of cancer for Aboriginal and Torres Strait Islander Australians: time for a coordinated, collaborative, priority-driven, Indigenous-led research program. Medical Journal of Australia, 194(10), 530-531.
Scopus22 WoS20 Europe PMC142011 Olver, I. (2011). Improving cancer treatment by addressing legislative and regulatory issues. Public health, 125(12), 876-881.
Scopus2 WoS2 Europe PMC12011 Winstanley, M. H., Pratt, I. S., Chapman, K., Griffin, H. J., Croager, E. J., Olver, I. N., . . . Slevin, T. J. (2011). Alcohol and cancer: A position statement from Cancer Council Australia. Medical Journal of Australia, 194(9), 479-482.
Scopus46 WoS44 Europe PMC232011 Olver, I., Marine, F., & Grogan, P. (2011). Disparities in cancer care in Australia and the Pacific. Oncologist, 16(7), 930-934.
Scopus17 WoS14 Europe PMC102011 Olver, I., Molassiotis, A., Aapro, M., Herrstedt, J., Grunberg, S., & Morrow, G. (2011). Antiemetic research: Future directions. Supportive Care in Cancer, 19(SUPPL. 1), S49-S55.
Scopus36 WoS30 Europe PMC212011 Olver, I., Clark-Snow, R., Ballatori, E., Espersen, B., Bria, E., & Jordan, K. (2011). Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive Care in Cancer, 19(SUPPL. 1), S33-S36.
Scopus11 WoS9 Europe PMC62011 Olver, I., Falleiro, S., Marson, M., & Bishop, J. (2011). A case study of a single ethics committee for multicentre trials. Medical Journal of Australia, 195(10), 582-583.
Scopus2 WoS2 Europe PMC22011 Hegarty, M., Abernethy, A., Olver, I., & Currow, D. (2011). Former palliative caregivers who identify that additional spiritual support would have been helpful in a population survey. Palliative Medicine, 25(3), 266-277.
Scopus16 WoS14 Europe PMC92011 Olver, I. N. (2011). Cancer clinical trials in Australia. Medical Journal of Australia, 194(8), 382-383.
Scopus1 WoS12011 Colagiuri, R., Hill, D. J., Johnson, G. J., Lalor, E., Moodie, R., Olver, I. N., . . . Greenland, R. J. (2011). Time for global action on chronic disease. Medical Journal of Australia, 194(4), 158-159.
Scopus1 WoS22011 Roscoe, J., Morrow, G., Aapro, M., Molassiotis, A., & Olver, I. (2011). Anticipatory nausea and vomiting. Supportive Care in Cancer, 19(10), 1533-1538.
Scopus126 WoS104 Europe PMC732011 Olver, I. N. (2011). Overview of complementary and alternative medicine. Cancer Forum, 35(1), 3-6. 2010 Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gebski, V. J., . . . Toner, G. C. (2010). Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: Updated analysis of a randomized trial. Journal of the National Cancer Institute, 102(16), 1253-1262.
Scopus55 WoS44 Europe PMC272010 Olver, I. N. (2010). A case study evaluation of ethics review systems for multicentre clinical trials [2]. Medical Journal of Australia, 192(5), 293.
2010 Sly, P. D., Chase, R., Kolbe, J., Thompson, P., Gupta, L., Daube, M., . . . Vallance, D. (2010). Asbestos still poses a threat to global health: Now is the time for action. Medical Journal of Australia, 193(4), 198-199.
Scopus7 WoS5 Europe PMC52010 Roila, F., Herrstedt, J., Aapro, M., Gralla, R. J., Einhorn, L. H., Ballatori, E., . . . Warr, D. (2010). Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: Results of the Perugia consensus conference. Annals of Oncology, 21(SUPPL. 5), v232-v243.
Scopus600 WoS484 Europe PMC3572010 Dresemann, G., Weller, M., Rosenthal, M. A., Wedding, U., Wagner, W., Engel, E., . . . Nikolova, Z. (2010). Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. Journal of Neuro-Oncology, 96(3), 393-402.
Scopus126 WoS114 Europe PMC922010 Fitzpatrick, K. L., Boult, M., & Fitridge, R. A. (2010). A case study evaluation of ethics review systems for multicentre clinical trials [1]. Medical Journal of Australia, 192(5), 293.
WoS12010 Tan, H., Wilson, A., Olver, I., & Barton, C. (2010). Recruiting palliative patients for a large qualitative study: Some ethical considerations and staff dilemmas. Explore: The Journal of Science & Healing, 6(3), 159-165.
Scopus12 WoS11 Europe PMC82010 Olver, I. (2010). Cancer - Principles & Practice of Oncology Volumes One and Two, 8th Edition. CANCER FORUM, 34(1), 58-59. 2009 Olver, I. (2009). MEDICAL ONCOLOGY GROUP OF AUSTRALIA (MOGA)/NOVARTIS CANCER ACHIEVEMENT AWARD. CANCER FORUM, 33(1), 34-36. 2009 Gandhi, M. K. (2009). What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?. MEDICAL JOURNAL OF AUSTRALIA, 190(8), 461.
WoS1 Europe PMC12009 Olver, I. (2009). Reply. Australian Life Scientist, 6(6), 15. 2009 Khan, O. A., Ranson, M., Michael, M., Olver, I., Levitt, N. C., Mortimer, P., . . . Middleton, M. R. (2009). Erratum: AAA phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer (British Journal of Cancer (2008) 98: (1614-1618) DOI: 10.1038/sj.bjc.6604366)). British Journal of Cancer, 101(3), 550.
WoS12009 Olver, I. N., & Whitford, H. S. (2009). A randomized controlled trial of the effect of intercessory prayer on the spiritual wellbeing and quality of life of patients with cancer.. J Clin Oncol, 27(15_suppl), e20708. 2009 Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gurney, H., . . . Australia and New Zealand Germ Cell Trials Group. (2009). Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: Updated analysis of a randomized trial with 8 years follow-up.. J Clin Oncol, 27(15_suppl), 5016. 2009 Beckmann, K., Olver, I., Young, G., Roder, D., Foreman, L., & Wilson, B. (2009). Patient and carer perceptions of cancer care in South Australia. Australian Health Review, 33(4), 645-655.
Scopus2 WoS2 Europe PMC12009 Eliott, J., & Olver, I. (2009). Hope, Life, and Death: A Qualitative Analysis of Dying Cancer Patients' Talk About Hope. Death Studies, 33(7), 609-638.
Scopus85 WoS72 Europe PMC432009 Olver, I., Whitford, H., Denson, L., Peterson, M., & Olver, S. (2009). Improving informed consent to chemotherapy: A randomized controlled trial of written information versus an interactive multimedia CD-ROM. Patient Education and Counseling, 74(2), 197-204.
Scopus37 WoS38 Europe PMC242009 Pawlik, T. M., Olver, I. N., Storm, C. D., & Rodriguez, M. A. (2009). Can physicians refuse treatment to patients who smoke?. Journal of Oncology Practice, 5(5), 250-251.
Scopus3 WoS52009 Olver, I. N., & Haines, I. E. (2009). What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?. Medical Journal of Australia, 190(2), 74-77.
Scopus11 WoS11 Europe PMC62009 Olver, I. N., & Haines, I. E. (2009). In reply. Medical Journal of Australia, 190(8), 461.
Scopus12009 Haines, I. E., & Olver, I. (2009). Are guidelines on use of colony-stimulating factors in solid cancers flawed?. Internal Medicine Journal, 39(4), 259-262.
Scopus6 WoS4 Europe PMC42009 Olver, I. (2009). Playing gene monopoly. Australian Life Scientist, 6(6), 14. 2009 Olver, I. N., & Haines, I. E. (2009). What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century? <i>REPLY</i>. MEDICAL JOURNAL OF AUSTRALIA, 190(8), 461.
WoS12008 Olver, I. N., & Eliott, J. (2008). Patients' use of humour in discussing sensitive end-of-life issues. JOURNAL OF CLINICAL ONCOLOGY, 26(15), 1 page.
2008 Olver, I., & Eliott, J. (2008). The role of humour in communicating with patients about end-of-life issues. PSYCHO-ONCOLOGY, 17, S31-S32. 2008 Shepherd, L., Goldstein, D., Olver, I., & Parle, M. (2008). Enhancing psychosocial care for people with cancer in rural communities: What can remote counselling offer?. Australian Health Review, 32(3), 423-438.
Scopus26 WoS23 Europe PMC162008 Clayton, J. M., Hancock, K., Parker, S., Butow, P. N., Walder, S., Carrick, S., . . . Tattersall, M. H. N. (2008). Sustaining hope when communicating with terminally ill patients and their families: A systematic review. Psycho-Oncology, 17(7), 641-659.
Scopus244 WoS205 Europe PMC1532008 Haines, I. E., & Olver, I. N. (2008). Are self-regulation and declaration of conflict of interest still the benchmark for relationships between physicians and industry?. Medical Journal of Australia, 189(5), 263-266.
Scopus14 WoS16 Europe PMC72008 Olver, I. (2008). An informed choice. Australian Doctor, (28/MAR.), 20. 2008 Olver, I. N., & Grogan, P. B. (2008). Cancer adds further urgency to prioritising obesity control. Medical Journal of Australia, 189(4), 191-192.
2008 Olver, I. N. (2008). Prevention of chemotherapy-induced nausea and vomiting: Focus on fosaprepitant. Therapeutics and Clinical Risk Management, 4(2), 501-506.
Scopus12 Europe PMC52008 Olver, I. N. (2008). Trastuzumab as the laed monoclonal antibody in advanced breast cancer: Choosing which patient and when. Future Oncology, 4(1), 125-131.
Scopus7 WoS8 Europe PMC42008 Luckett, T., Butow, P. N., King, M. T., & Olver, I. N. (2008). Psycho-social issues in long-term survivors of testicular cancer: Directions for future research. Asia-Pacific Journal of Clinical Oncology, 4(3), 125-131.
Scopus11 WoS92008 Eliott, J., & Olver, I. (2008). Dying cancer patients talk about euthanasia. Social Science & Medicine, 67(4), 647-656.
Scopus27 WoS20 Europe PMC152008 Khan, O., Ranson, M., Michael, M., Olver, I., Levitt, N., Mortimer, P., . . . Middleton, M. (2008). A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer. British Journal of Cancer, 98(10), 1614-1618.
Scopus48 WoS43 Europe PMC292008 Olver, I., & Eliott, J. (2008). The perceptions of do-not-resuscitate policies of dying patients with cancer. Psycho-Oncology, 17(4), 347-353.
Scopus25 WoS23 Europe PMC192008 Eliott, J., & Olver, I. (2008). Choosing between life and death: Patient and family perceptions of the decision not to resuscitate the terminally ill cancer patient. Bioethics, 22(3), 179-189.
Scopus35 WoS31 Europe PMC222008 Eliott, J., Kealey, C., & Olver, I. (2008). (Using) complementary and alternative medicine: The perceptions of palliative patients with cancer. Journal of Palliative Medicine, 11(1), 58-67.
Scopus35 WoS23 Europe PMC172008 Whitford, H., Olver, I., & Peterson, M. (2008). Spirituality as a core domain in the assessment of quality of life in oncology. Psycho-Oncology, 17(11), 1121-1128.
Scopus116 WoS106 Europe PMC702008 Botten, R., Yeoh, E. K., Matteo, D. I. A., Butters, J., Dhillon, V., Holloway, R. H., . . . Fenech, M. (2008). Cytokinesis blocked micronucleus (CBMN) assay is predictive of gastrointestinal (GI) sequelae 2 years following radiation therapy (RT) for prostate carcinoma (CAP) while micronutrients reduce their severity. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23, A287. 2008 Canepari, M., Vogt, K., & Zecevic, D. (2008). Combining Voltage and Calcium Imaging from Neuronal Dendrites. CELLULAR AND MOLECULAR NEUROBIOLOGY, 28(8), 1079-1093.
WoS43 Europe PMC302008 Cain, J. M., Storm, C., & Olver, I. (2008). Making the decision to not attempt resuscitation. Journal of Oncology Practice, 4(2), 99-100.
2007 Mayr, P., & Walter, A. -K. (2007). An exploratory study of Google Scholar. ONLINE INFORMATION REVIEW, 31(6), 814-830.
WoS622007 Olver, I. (2007). Xerostomia [3]. Australian Prescriber, 30(1), 4. 2007 Olver, I., Shepherd, L., & Selva-Nayagam, S. (2007). Beyond the bush telegraph: Telehealth for remote cancer control and support. Cancer Forum, 31(2), 77-80.
Scopus4 WoS52007 Olver, I. (2007). Xerostomia comment. AUSTRALIAN PRESCRIBER, 30(1), 4. 2007 Borgas, M., Yeoh, E., Bochner, M., Butters, J., Van Doorn, T., Farshid, G., . . . Rush, G. (2007). Feasibility study on the MammoSite in early-stage breast cancer: initial experience. Australasian Radiology, 51(1), 53-61.
Scopus3 WoS4 Europe PMC22007 Eliott, J., & Olver, I. (2007). Autonomy and the family as (in) appropriate surrogates for DNR decisions: A qualitative analysis of dying cancer patients' talk. Journal of Clinical Ethics, 18(3), 206-218.
Scopus11 WoS7 Europe PMC52007 Eliott, J., & Olver, I. (2007). Response from Eliott and Olver. Journal of Clinical Ethics, 18(3), 233-234. 2007 Luke, C., Gill, P., Birrell, S., Humeniuk, V., Borg, M., Karapetis, C., . . . Roder, D. (2007). Treatment and survival from breast cancer: The experience of patients at South Australian teaching hospitals between 1977 and 2003. Journal of Evaluation in Clinical Practice, 13(2), 212-220.
Scopus7 WoS7 Europe PMC52007 Joshi, R., Olver, I., Keefe, D., Marafioti, T., & Smith, K. (2007). A phase I study to assess the safety and activity of topical lovastatin (FP252S) for the prevention of chemotherapy-induced alopecia. Supportive Care in Cancer, 15(9), 1109-1112.
Scopus6 WoS3 Europe PMC32007 Eliott, J., & Olver, I. (2007). The Implications of Dying Cancer Patients' Talk on Cardiopulmonary Resuscitation and Do-Not-Resuscitate Orders. Qualitative Health Research, 17(4), 442-455.
Scopus22 WoS16 Europe PMC102007 Brown, M., Wilkinson, C., Rudzi, Z., & Olver, I. (2007). Why we will need to learn new skills to control cancer. Internal Medicine Journal, 37(3), 201-204.
Scopus4 WoS4 Europe PMC22007 Eliott, J., & Olver, I. (2007). Hope and hoping in the talk of dying cancer patients. Social Science & Medicine, 64(1), 138-149.
Scopus105 WoS93 Europe PMC582007 Singhal, N., Brown, M., Brown, G., Hall, V., & Olver, I. (2007). Assessment of parameters of response to combined modality treatment of locally advanced breast cancer. BREAST, 16, S52.
2007 Olver, I. N. (2007). Challenges in cancer control in Australia. Medical Journal of Australia, 186(11), 556-557.
Scopus1 WoS1 Europe PMC12007 Clayton, J. M., Hancock, K. M., Butow, P. N., Tattersall, M. H. N., Currow, D. C., Adler, J., . . . Yates, P. (2007). Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers.. The Medical journal of Australia, 186(12 Suppl), S77-S105.
Scopus315 Europe PMC632007 Olver, I., Shelukar, S., & Thompson, K. C. (2007). Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2(1), 13-18.
WoS41 Europe PMC262007 Olver, I. N., Byrne, M. J., Walpole, E., Vorobiof, D., Jacobs, C., Maart, K., . . . Pinel, M. C. (2007). Phase II study of IV vinflunine in patients with chemotherapy naive metastatic malignant melanoma. European Journal of Cancer, 43(12), 1829-1832.
Scopus11 WoS11 Europe PMC82006 Olver, I. N. (2006). The development of future research strategies from reviewing antiemetic trials for chemotherapy induced emesis.. Reviews on recent clinical trials, 1(1), 61-66.
Scopus5 WoS5 Europe PMC42006 Olver, I. N. (2006). Antiemetic research: Solving patient problems. Cancer Forum, 30(2), 123-126. 2006 Sambrook, P., Olver, I., & Goss, A. (2006). Bisphosphonates and the osteonecrosis of the jaw. Australian Family Physician, 35(10), 801-803.
Scopus75 Europe PMC452006 Olver, I. (2006). Caring for dying people of different faiths, 3rd edition. Psycho-Oncology, 15(5), 446-447.
2006 Pittman, K., Olver, I., Koczwara, B., Kotasek, D., Patterson, W., Keefe, D., . . . Price, T. (2006). Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study. British Journal of Cancer, 95(10), 1309-1313.
Scopus31 WoS29 Europe PMC222006 Millward, M., House, C., Bowtell, D., Webster, L., Olver, I., Gore, M., . . . Zalcberg, J. (2006). The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study. British Journal of Cancer, 95(7), 829-834.
Scopus55 WoS45 Europe PMC392006 Marcu, L., Bezak, E., & Olver, I. (2006). Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach. Physics in Medicine and Biology, 51(15), 3625-3639.
Scopus25 WoS21 Europe PMC162006 Goldstein, D., Ackland, S., Bell, D., Olver, I., Davis, I., Rosenthal, M., . . . Byrne, M. (2006). Phase II study of vinflunine in patients with metastatic renal cell carcinoma. Investigational New Drugs, 24(5), 429-434.
Scopus17 WoS14 Europe PMC152006 O'Brien, P., Roos, D., Pratt, G., Liew, K., Barton, M., Poulsen, M., . . . Trotter, G. (2006). Combined-modality therapy for primary central nervous system lymphoma: Long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group). International Journal of Radiation Oncology Biology Physics, 64(2), 408-413.
Scopus81 WoS66 Europe PMC532006 Marcu, L., & Olver, I. (2006). Tirapazamine: from bench to clinical trials. Current Clinical Pharmacology, 1(1), 71-79.
Scopus94 WoS90 Europe PMC452006 Eliott, J. A., & Olver, I. N. (2006). The patient in the family: A discursive analytic study of dying patients' (and their family's) talk on the do-not-resuscitate decision. PSYCHO-ONCOLOGY, 15(2), S233-S234. 2006 Eliott, J., & Olver, I. (2006). Hoping is better than hope: A discursive analysis of dying cancer patients' talk. AUSTRALIAN JOURNAL OF PSYCHOLOGY, 58, 27. 2006 Olver, I. N., & Eliott, J. A. (2006). The meanings of 'hope' to patients living and dying with cancer. PSYCHO-ONCOLOGY, 15(2), S352-S353. 2006 Eliott, J. A., Kealey, C. P., & Olver, I. N. (2006). (Using) complementary and alternative medicine: A discourse analytic study of cancer patients' talk. PSYCHO-ONCOLOGY, 15(2), S117. 2006 Olver, I. N. (2006). ANTIEMETIC RESEARCH: SOLVING PATIENT PROBLEMS. CANCER FORUM, 30(2), 122-126. 2006 Wang, X. D., Jin, Z. S., Pei, X. R., Yang, J. J., & Zhang, Z. J. (2006). A novel method to prepare potassium sodium titanate nanotubes. CHINESE CHEMICAL LETTERS, 17(9), 1275-1278.
WoS42006 Roila, F., Aapro, M., Ballatori, E., Borjeson, S., Clark-Snow, R. A., Del Favero, A., . . . Warr, D. (2006). Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the 2004 Perugia International Antiemetic Consensus Conference. Annals of Oncology, 17(1), 20-28.
Scopus310 Europe PMC1492006 Koczwara, B., Barton, M. B., Tattersall, M. H., Turner, D. R., Olver, I. N., & Starmer, D. L. (2006). How not to effect change in curricula [3]. Medical Journal of Australia, 185(1), 52.
Scopus3 WoS4 Europe PMC22006 Olver, I. N. (2006). Xerostomia: A common adverse effect of drugs and radiation. Australian Prescriber, 29(4), 97-98.
Scopus10 WoS42006 Hedayati, H., Whitford, H., & Olver, I. (2006). Improving the chemotherapy consent process: Longitudinal assessment of patient recall. PSYCHO-ONCOLOGY, 15(2), S263. 2006 Olver, I., & Whitford, H. (2006). Improving informed consent to chemotherapy: Written information versus an interactive CD-ROM. PSYCHO-ONCOLOGY, 15(2), S353. 2006 Whitford, H., Olver, I., & Peterson, M. (2006). Spirituality as a core domain in the assessment of quality of life in oncology: An Australian perspective. PSYCHO-ONCOLOGY, 15(2), S457-S458. 2006 Lewis, C. R., Olver, I. N., Walpole, E., Shannon, C., Pavlakis, N., Dalley, D., . . . Lybrand, S. (2006). Outcomes and health status of patients undergoing usual care for highly emetogenic chemotherapy.. J Clin Oncol, 24(18_suppl), 18591. 2006 Olver, I. N., & Eliott, J. A. (2006). The meanings of "hope" to patients with cancer, nearing the end of their lives.. J Clin Oncol, 24(18_suppl), 18567. 2006 Di Matteo, A. C., Botten, R. J., Butters, J., Salisbury, C., Dhillon, V., Fenech, M., . . . Yeoh, E. K. (2006). The Cytokinesis Blocked Micronucleus (CBMN) assay correlates with acute anorectal dysfunction after radiation therapy for carcinoma of the prostate and may predict individual radiosensitivity. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21, A342. 2005 Kris, M. G., Hesketh, P. J., Herrstedt, J., Rittenberg, C., Einhorn, L. H., Grunberg, S., . . . Ballatori, E. (2005). Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy. Supportive Care in Cancer, 13(2), 85-96.
Scopus113 WoS79 Europe PMC622005 Cox, K. (2005). Achieving equal standards in medical student education: is a national exit examination the answer?. MEDICAL JOURNAL OF AUSTRALIA, 183(3), 167-168.
WoS1 Europe PMC12005 Koczwara, B., Barton, M., Coventry, B., Millar, J., Olver, I., Schwarz, M., & Schwarz, M. (2005). Cancer curriculum in the Asia-Pacific: opportunities and challenges in the age of globalization. Asia Pacific Journal of Clinical Oncology, 1(4), 109-113.
2005 Burmeister, B., Smithers, B., Gebski, V., Fitzgerald, L., Simes, R., Devitt, P., . . . Denham, J. (2005). Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. The Lancet Oncology, 6(9), 659-668.
Scopus869 Europe PMC5752005 Eliott, J., & Olver, I. (2005). End-of-life decision making is more than rational. Communication and Medicine, 2(1), 21-34.
Scopus13 Europe PMC92005 Feyer, P., Maranzano, E., Molassiotis, A., Clark-Snow, R., Roila, F., Warr, D., & Olver, I. (2005). Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines. Supportive Care in Cancer, 13(2), 122-128.
Scopus48 WoS36 Europe PMC282005 Roila, F., Feyer, P., Maranzano, E., Olver, I., Clark-Snow, R., Warr, D., & Molassiotis, A. (2005). Antiemetics in children receiving chemotherapy. Supportive Care in Cancer, 13(2), 129-131.
Scopus25 WoS19 Europe PMC142005 Aapro, M., Molassiotis, A., & Olver, I. (2005). Anticipatory nausea and vomiting. Supportive Care in Cancer, 13(2), 117-121.
Scopus102 WoS75 Europe PMC512005 Olver, I., Keefe, D., Myers, M., & Caruso, D. (2005). A phase I study of prolonged ambulatory infusion of ifosfamide with oral mesna. Chemotherapy, 51(2-3), 142-146.
Scopus3 WoS2 Europe PMC12005 Koczwara, B., Tattersall, M., Barton, M., Coventry, B., Dewar, J., Miller, J., . . . Stockler, M. (2005). Achieving equal standards in medical student education: is a national exit examination the answer?. Medical Journal of Australia, 182(5), 228-230.
Scopus17 WoS19 Europe PMC112005 Maranzano, E., Feyer, P., Molassiotis, A., Rossi, R., Clark-Snow, R., Olver, I., . . . Roila, F. (2005). Evidence-based recommendations for the use of antiemetics in radiotherapy. Radiotherapy and Oncology, 76(3), 227-233.
Scopus44 WoS30 Europe PMC192005 Olver, I. (2005). Update on anti-emetics for chemotherapy-induced emesis. Internal Medicine Journal, 35(8), 478-481.
Scopus19 WoS15 Europe PMC132005 Luke, C., Koczwara, B., Moore, J., Olver, I., Penniment, M., Pittman, K., . . . Roder, D. (2005). Treatment and survival from colorectal cancer: The experience of patients at South Australian teaching hospitals between 1980 and 2002. Clinical Oncology, 17(5), 372-381.
Scopus14 WoS12 Europe PMC72005 Olver, I., Keefe, D., & Myers, M. (2005). Phase II study of prolonged ambulatory infusion carboplatin and oral etoposide for patients progressing through hormonal therapy for prostate cancer. Internal Medicine Journal, 35(7), 405-408.
Scopus4 WoS3 Europe PMC32005 Seshadri, T., Prince, H., Bell, D., Coughlin, P., James, P., Richardson, G., . . . Stewart, J. (2005). The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer. Medical Journal of Australia, 182(9), 453-457.
Scopus26 WoS18 Europe PMC152005 Kris, M., Hesketh, P., Herrstedt, J., Rittenberg, C., Einhorn, L., Grunberg, S., . . . Ballatori, E. (2005). Erratum: Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy. Supportive Care in Cancer, 13(7), 562.
2005 Marcu, L., Bezak, E., Olver, I., & Van Doorn, T. (2005). Tumour resistance to cisplatin: a modelling approach. Physics in Medicine and Biology, 50(1), 93-102.
Scopus20 WoS18 Europe PMC112005 Olver, I., Taylor, A., & Whitford, H. (2005). Relationships between patients' pretreatment expectations of toxicities and post chemotherapy experiences. Psycho-Oncology, 14(1), 25-33.
Scopus30 WoS28 Europe PMC242005 Roila, F., Feyer, P., Maranzano, E., Olver, I., Clark-Snow, R., Warr, D., & Molassiotis, A. (2005). Erratum: Antiemetics in children receiving chemotherapy: (Supportive Care in Cancer (2004) DOI: 10.1007/s00520-004-0702-6). Supportive Care in Cancer, 13(2), 132.
2005 Olver, I., Brooksbank, M., Champion, N., & Keeley, J. (2005). The use of videophones to enhance palliative care outreach nursing in remote areas. Progress in Palliative Care, 13(5), 263-266.
Scopus14 WoS152004 Olver, I. (2004). Two decades of progress in treating chemotherapy induced emesis. Cancer Forum, 28(3), 140-143.
Scopus22004 Marcu, L., Van Doorn, T., & Olver, I. (2004). Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas. Physics in Medicine and Biology, 49(16), 3767-3779.
Scopus35 WoS31 Europe PMC232004 Wakefield, M., Olver, I., Whitford, H., & Rosenfeld, E. (2004). Motivational interviewing as a smoking cessation intervention for patients with cancer: Randomized controlled trial. Nursing Research, 53(6), 396-405.
Scopus71 WoS67 Europe PMC502004 Yap, Y., Coleman, M., & Olver, I. (2004). Aggressive mixed epithelial-stromal tumour of the kidney treated with chemotherapy and radiotherapy. The Lancet Oncology, 5(12), 747-749.
Scopus49 WoS43 Europe PMC362004 Olver, I. (2004). Aprepitant in antiemetic combinations to prevent chemotherapy-induced nausea and vomiting. International Journal of Clinical Practice, 58(2), 201-206.
Scopus14 WoS11 Europe PMC52004 Schofield, P., Ball, D., Smith, J., Borland, R., O'Brien, P., Davis, S., . . . Joseph, D. (2004). Optimism and survival in lung carcinoma patients. Cancer, 100(6), 1276-1282.
Scopus61 WoS43 Europe PMC292003 Eliott, J., & Olver, I. (2003). Perceptions of "good palliative care" orders: A discursive study of cancer patients' comments. Journal of Palliative Care, 6(1), 59-68.
Scopus6 Europe PMC22003 Eliott, J., & Olver, I. (2003). Legitimating do-not-resuscitate orders: A discursive study of cancer patients' speech. Journal of Palliative Care, 19(2), 100-106.
Scopus7 WoS7 Europe PMC42003 Doyle, J., Brinkworth, C., Wegener, K., Carver, J., Llewellyn, L., Olver, I., . . . Tyler, M. (2003). nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications. FEBS Journal, 270(6), 1141-1153.
Scopus78 WoS66 Europe PMC472003 Marcu, L., Van Doorn, T., & Olver, I. (2003). Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer - a review of their cooperation. Acta Oncologica, 42(4), 315-325.
Scopus56 WoS47 Europe PMC372003 Liebert, B., Parle, M., Roberts, C., Redman, S., Carrick, S., Gallagher, J., . . . Trotter, J. (2003). An evidence-based specialist breast nurse role in practice: a multicentre implementation study. EUROPEAN JOURNAL OF CANCER CARE, 12(1), 91-97.
WoS21 Europe PMC162003 Olver, I. (2003). Telemedicine in oncology.. Current problems in dermatology, 32, 121-126.
Scopus4 Europe PMC32002 Marcu, L., Van Doorn, T., Zavgorodni, S., & Olver, I. (2002). Growth of a virtual tumour using probabilistic methods of cell generation. Australasian Physical and Engineering Sciences in Medicine, 25(4), 155-161.
Scopus21 Europe PMC132002 Healey, T., Olver, I., & Selva-Nayagam, S. (2002). Immunoproliferative small intestinal disease, two cases in the Northern Territory. Internal Medicine Journal, 32(1-2), 47-49.
Scopus3 WoS3 Europe PMC22002 Borbasi, S., Cameron, K., Quested, B., Olver, I., To, L., & Evans, D. (2002). More than a sore mouth: Patients' experience of oral mucositis. Oncology Nursing Forum, 29(7), 1051-1057.
Scopus55 Europe PMC492002 Eliott, J., & Olver, I. (2002). The discursive properties of "hope": A qualitative analysis of cancer patients' speech. Qualitative Health Research, 12(2), 173-193.
Scopus107 WoS84 Europe PMC562002 Olver, I., Eliott, J., & Mortimer, J. (2002). Cancer patients' perceptions of do not resuscitate orders. Psycho-Oncology, 11(3), 181-187.
Scopus16 WoS14 Europe PMC112002 Olver, I., Hercus, T., Lopez, A., Vadas, M., Somogyi, A., Doyle, I., . . . Wigley, P. (2002). A phase I study of the GM-CSF antagonist E21R. Cancer Chemotherapy and Pharmacology, 50(3), 171-178.
Scopus8 WoS8 Europe PMC62002 Eliott, J., & Olver, I. (2002). Legitimating do-not-resuscitate orders: A qualitative study of cancer patients' talk. AUSTRALIAN JOURNAL OF PSYCHOLOGY, 54(2), 116. 2002 Castiglione-Gertsch, M., Price, K. N., Goldhirsch, A., Coates, A. S., Colleoni, M., Nasi, M. L., . . . Castiglione-Gertsch, M. (2002). Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trial. Journal of the National Cancer Institute, 94(14), 1054-1065.
Scopus150 WoS130 Europe PMC812001 Roberts, A. W., Gunawardana, D., Rosenthal, M. A., Green, M., Basser, R. L., Davis, I. D., . . . Ashley, D. (2001). Phase I study of the effects of progenipoietin (SD-9427) on hematopoiesis.. BLOOD, 98(11), 299A.
WoS12001 Ahrens, C., Denson, L., Moar, K., & Olver, I. N. (2001). Written informed consent: Patient comprehension and contributing factors. AUSTRALIAN JOURNAL OF PSYCHOLOGY, 53, 136. 2001 Olver, I. (2001). Telemedicine: prospects and realities. Medicine Today, 2(1), 81-84. 2001 Boyer, M., Mitchell, P., Goldstein, D., Millward, M., Olver, I., Clarke, S., . . . Davis, I. (2001). Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer. Lung Cancer, 32(1), 89-94.
Scopus3 WoS3 Europe PMC22001 Toner, G., Stockler, M., Boyer, M., Jones, M., Thomson, B., Harvey, V., . . . Simes, R. (2001). Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Lancet, 357(9258), 739-745.
Scopus102 WoS77 Europe PMC592001 Olver, I., Davy, M., Luftner, D., Park, S., Egorin, M., Ellis, A., & Webster, L. (2001). A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer. Cancer Chemotherapy and Pharmacology, 48(2), 109-114.
Scopus3 WoS4 Europe PMC22000 Olver, I. (2000). Guest Editorial - Nausea and Vomiting. Current Therapeutics, November 2, 7-9. 2000 Olver, I., & Selva-Nayagam, R. (2000). Evaluation of a telemedicine link between Darwin and Adelaide to facilitate cancer management. Telemedicine Journal and E-health, 6(2), 213-218.
Scopus59 WoS51 Europe PMC352000 Parnis, F., Olver, I., Kotasek, D., Norman, J., Taylor, A., Russell, J., . . . Marafioti, T. (2000). Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site. Annals of Oncology, 11(7), 883-884.
Scopus17 WoS16 Europe PMC142000 Olver, I. (2000). Chemotherapy for elderly patients with advanced cancer: is it worth it?. Australian Prescriber, 23(4), 80-82.
Scopus82000 Olver, I., Stephenson, J., & Schulze, D. (2000). A phase I study of prolonged ambulatory infusion carboplatin with oral etoposide showing activity in prostate cancer. Cancer Chemotherapy and Pharmacology, 46(4), 338-341.
Scopus4 WoS4 Europe PMC32000 O'Brien, P., Roos, D., Pratt, G., Liew, K., Barton, M., Poulsen, M., . . . Trotter, G. (2000). Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. Journal of Clinical Oncology, 18(3), 519-526.
Scopus211 WoS156 Europe PMC1132000 Webster, L., Olver, I., Stokes, K., Sephton, R., Hillcoat, B., & Bishop, J. (2000). A pharmacokinetic and phase II study of gallium nitrate in patients with non-small cell lung cancer. Cancer Chemotherapy and Pharmacology, 45(1), 55-58.
Scopus17 WoS12 Europe PMC52000 Rozek, T., Wegener, K., Bowie, J., Olver, I., Carver, J., Wallace, J., & Tyler, M. (2000). The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis: The solution structure of aurein 1.2. FEBS Journal, 267(17), 5330-5341.
Scopus261 WoS231 Europe PMC1352000 Olver, I., Wakefield, M., & Roberts, L. (2000). Community beliefs about cancer treatment and care in South Australia. Cancer Forum, 24(1), 18-19.
Scopus32000 Clarke, S. J., Zalcberg, J., Olver, I., Mitchell, P. L. R., Rischin, D., Dalley, D., . . . Davidson, Y. E. (2000). Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neck. Annals of Oncology, 11(2), 239-241.
Scopus12 WoS8 Europe PMC62000 Olver, I. N., & Eliott, J. (2000). Autonomy and end-of-life decision-making. PSYCHO-ONCOLOGY, 9(5), S37.
WoS12000 Wigley, P., Olver, I., Bardy, P., Donadieu, J., Lopez, A., Bastiras, S., . . . Verma, M. (2000). E21R: A GM-CSF analogue with potential as an anti-cancer agent.. CLINICAL CANCER RESEARCH, 6, 4559S. 2000 Ahrens, C., Densen, L., Moar, K., & Olver, I. (2000). Patient understanding of written consent to chemotherapy. PSYCHO-ONCOLOGY, 9(5), S73. 2000 Von Pawel, J., Von Roemeling, R., Gatzemeier, U., Boyer, M., Elisson, L. O., Clark, P., . . . Treat, J. (2000). Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Journal of Clinical Oncology, 18(6), 1351-1359.
Scopus278 WoS239 Europe PMC1361999 Taylor, A., Olver, I., Sivanthan, T., Chi, M., & Purnell, C. (1999). Observer error in grading performance status in cancer patients. European Journal of Cancer, 35(Suppl. 4), S363-S364.
1999 Castagnola, E., Viscoli, C., Olver, I. N., Price, T. J., & Patterson, W. K. (1999). Rifampicin as treatment for pruritus in malignant cholestasis: An example of an improper indication for anti-infective drugs (multiple letters). Supportive Care in Cancer, 7(3), 160.
Scopus2 Europe PMC21999 Kollias, J., Olver, I. N., Kissane, D. W., Clarke, D. M., Ikin, J., Bloch, S., . . . McKenzie, D. P. (1999). Psychological morbidity and quality of life in Australian women with early-stage breast cancer: A cross-sectional survey (multiple letters) [6]. Medical Journal of Australia, 170(5), 239-240.
Scopus11999 Olver, I. (1999). A mass of exam nerves. Current Therapeutics, 40(8), 44-46. 1999 Olver, I. (1999). Management of prostate cancer. Current Therapeutics, 40(7), 73-82. 1999 Tattersall, M., & Olver, I. (1999). Conflict of interests and advisory committees. International Journal of Pharmaceutical Medicine, 13(6), 325-328.
Scopus11999 Ball, D., Bishop, J., Smith, J., O'Brien, P., Davis, S., Ryan, G., . . . Joseph, D. (1999). A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: Final report of an Australian multi-centre trial. Radiotherapy and Oncology, 52(2), 129-136.
Scopus135 WoS119 Europe PMC811999 Bishop, J. F., Dewar, J., Toner, G. C., Smith, J., Tattersall, M. H. N., Olver, I. N., . . . Canetta, R. (1999). Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. Journal of Clinical Oncology, 17(8), 2355-2364.
Scopus198 WoS161 Europe PMC951999 Adams, W., Cartmill, J., Chapuis, P., Cunningham, I., Farmer, K. C., Hewett, P., . . . Waxman, B. (1999). Practice parameters for the management of colonic cancer II: Other issues. Recommendations of the Colorectal Surgical Society of Australia. Australian and New Zealand Journal of Surgery, 69(7), 472-478.
WoS51999 Moore, J., Hewett, P., Penfold, J. C., Adams, W., Cartmill, J., Chapuis, P., . . . Waxman, B. (1999). Practice parameters for the management of colonic cancer I: Surgical issues. Recommendations of the colorectal surgical society of Australia. Australian and New Zealand Journal of Surgery, 69(6), 415-421.
Scopus7 WoS3 Europe PMC31999 Basser, R., To, L., Collins, J., Begley, C., Keefe, D., Cebon, J., . . . Green, M. (1999). Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage ii or iii breast cancer: five-year follow-up. Journal of Clinical Oncology, 17(1), 82-92.
Scopus20 WoS17 Europe PMC101999 Taylor, A. E., Olver, I. N., Sivanthan, T., Chi, M., & Purnell, C. (1999). Observer error in grading performance status in cancer patients. Supportive Care in Cancer, 7(5), 332-335.
Scopus117 WoS100 Europe PMC781998 Basser, R., To, L., Begley, C., Maher, D., Juttner, C., Cebon, J., . . . Green, M. (1998). Rapid hematopoietic recovery after multicycle high-dose chemotherapy; enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor. Journal of Clinical Oncology, 16(5), 1899-1908.
WoS28 Europe PMC171998 Price, T. J., Patterson, W. K., & Olver, I. N. (1998). Rifampicin as treatment for pruritus in malignant cholestasis. Supportive Care in Cancer, 6(6), 533-535.
Scopus18 WoS18 Europe PMC71998 Millward, M. J., Webster, L. K., Rischin, D., Stokes, K. H., Toner, G. C., Bishop, J. F., . . . Woodcock, D. M. (1998). Phase I trial of cremophor EL with bolus doxorubicin. Clinical Cancer Research, 4(10), 2321-2329.
Scopus42 WoS35 Europe PMC211998 Olver, I. N., Green, M., Millward, M. J., & Bishop, J. F. (1998). Phase II study of acivicin in patients with recurrent high grade astrocytoma. Journal of Clinical Neuroscience, 5(1), 46-48.
Scopus14 WoS12 Europe PMC111998 Borg, M. F., Olver, I. N., & Hill, M. P. (1998). Rothmund-Thomson syndrome and tolerance of chemoradiotherapy. Australasian Radiology, 42(3), 216-218.
Scopus15 Europe PMC91998 Roila, F., Del Favero, A., Gralla, R. J., Tonato, M., Aapro, M. S., Andrews, P. L. R., . . . Stewart, A. (1998). Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus Conference. ANNALS OF ONCOLOGY, 9(8), 811-819.
WoS156 Europe PMC261998 Olver, I., Davy, M., Webster, L., Egorin, M., Luftner, D., & Park, S. H. (1998). A phase I trial with pharmacokinetics of paclitaxel and altretamine for ovarian cancer relapsing following cisplatin. ANNALS OF ONCOLOGY, 9, 68.
WoS11998 Kissane, D. W., Clarke, D. M., Ikin, J., Bloch, S., Smith, G. C., Vitetta, L., & McKenzie, D. P. (1998). Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. MEDICAL JOURNAL OF AUSTRALIA, 169(4), 192-196.
WoS174 Europe PMC1131997 Michael, M., Bishop, J. F., Levi, J. A., Bell, D. R., Zalcberg, J. R., Friedlander, M. L., . . . Toner, G. C. (1997). Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy. Medical Journal of Australia, 166(10), 520-523.
Scopus11 WoS10 Europe PMC31997 Bishop, J. F., Dewar, J., Toner, G., Tattersall, M. H., Olver, I., Ackland, S., . . . Stephenson, J. (1997). A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results. SEMINARS IN ONCOLOGY, 24(5), 5-9.
WoS51997 Olver, I., Paska, W., Depierre, A., Seitz, J. F., Stewart, D. J., Goedhals, L., . . . Wilkinson, J. R. (1997). The control of delayed nausea - Response. ANNALS OF ONCOLOGY, 8(6), 615-616.
1997 Beller, E., Tattersall, M., Lumley, T., Levi, J., Dalley, D., Olver, I., . . . Simes, R. J. (1997). Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial. Annals of Oncology, 8(3), 277-283.
Scopus74 WoS601997 Cunningham, D., Zalcberg, J. R., Rath, U., Oliver, I., Van Cutsem, E., Svensson, C., . . . Perez-Manga, G. (1997). Erratum: Final results of a randomised trial comparing 'Tomudex'® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. (Ann Oncol (1996) 7 (9) (961-965)). Annals of Oncology, 8(4), 407.
Scopus11997 Bishop, J. F., Dewar, J., Toner, G., Tattersall, M. H., Olver, I., Ackland, S., . . . Stephenson, J. (1997). A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.. Seminars in oncology, 24(5 Suppl 17), S17-5-S17-9.
Europe PMC31997 Michael, M., Toner, G. C., Olver, I. N., Fenessy, A., & Bishop, J. F. (1997). Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancer. American Journal of Clinical Oncology: Cancer Clinical Trials, 20(3), 259-262.
Scopus1 WoS2 Europe PMC11997 Boyer, M. J., Zalcberg, J., Olver, I. N., Millward, M. J., Richardson, G., & McKeage, M. J. (1997). Phase I study of paclitaxel and oral etoposide in previously uutreated non-small-cell and extensive small-cell lung cancer. Annals of Oncology, 8(5), 485-489.
Scopus7 WoS7 Europe PMC41997 Bishop, J. F., Dewar, J., Toner, G. C., Tattersall, M. H., Olver, I. N., Ackland, S., . . . Stephenson, J. (1997). Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand.. Oncology (Williston Park, N.Y.), 11(4 Suppl 3), 19-23.
Europe PMC131997 Beller, E., Tattersall, M., Lumley, T., Levi, J., Dalley, D., Olver, I., . . . Simes, R. J. (1997). Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.. Annals of oncology : official journal of the European Society for Medical Oncology, 8(3), 277-283.
Europe PMC451997 Joschko, M. A., Webster, L. K., Bishop, J. F., Groves, J., Yuen, K., Olver, I. N., . . . Ball, D. L. (1997). Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft. Cancer Chemotherapy and Pharmacology, 40(6), 534-539.
Scopus14 WoS14 Europe PMC91997 Ball, D., Smith, J., Bishop, J., Olver, I., Davis, S., O'Brien, P., . . . Millward, M. (1997). A phase III study of radiotherapy with and without continuous-infusion fluorouracil as palliation for non-small-cell lung cancer. British Journal of Cancer, 75(5), 690-697.
Scopus52 WoS40 Europe PMC261997 Parnis, F., Olver, I., Sandeman, T., Bishop, J., & Laidlaw, C. (1997). A phase II trial of cisplatin and interferon alpha 2b in patients with advanced bladder cancer.. American Journal of Clinical Oncology CCT, 20(3), 319-321.
Scopus4 WoS4 Europe PMC11996 O'Brien, P., Roos, D., Liew, K., Trotter, G., Barton, M., Walker, Q., . . . Olver, I. (1996). Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Medical Journal of Australia, 165(8), 424-427.
Scopus20 WoS18 Europe PMC61996 Olver, I., Paska, W., Depierre, A., Seitz, J. F., Stewart, D. J., Goedhals, L., . . . Wilkinson, J. R. (1996). A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study Group.. Annals of oncology : official journal of the European Society for Medical Oncology, 7(9), 945-952.
Europe PMC401996 Olver, I. N. (1996). Antiemetic Study Methodology: Recommendations for Future Studies. Oncology (Switzerland), 53(1), 96-101.
Scopus13 WoS12 Europe PMC101996 Olver, I. N., Craft, P. S., Clingan, P. R., Kearsley, J. H., Planner, R. S., Van Hazel, G. A., . . . Pearson, L. L. (1996). An open multicentre study of tropisetron for cisplatin-induced nausea and vomiting. Medical Journal of Australia, 164(6), 337-340.
Scopus3 WoS4 Europe PMC11996 Olver, I. N., Hughes, P. G., Smith, J. G., Narayan, K., & Bishop, J. F. (1996). Concurrent radiotherapy and continuous ambulatory infusion 5-fluorouracil in advanced head and neck cancer. European Journal of Cancer, 32(2), 249-254.
Scopus13 WoS11 Europe PMC121996 Millward, M. J., Bishop, J. F., Friedlander, M., Levi, J. A., Goldstein, D., Olver, I. N., . . . Bell, D. R. (1996). Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology, 14(1), 142-148.
Scopus70 WoS78 Europe PMC401996 Olver, I., Paska, W., Depierre, A., Seitz, J. F., Stewart, D. J., Goedhals, L., . . . Wilkinson, J. R. (1996). A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Annals of Oncology, 7(9), 945-952.
Scopus68 WoS531996 Cunningham, D., Zalcberg, J. R., Rath, U., Oliver, I., Van Cutsem, E., Svensson, C., . . . Perez-Manga, G. (1996). Final results of a randomised trial comparing 'Tomudex'® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Annals of Oncology, 7(9), 961-965.
Scopus241 Europe PMC1041996 Cunningham, D., Zalcberg, J. R., Rath, U., Olver, I., Van Cutsem, E., Svensson, C., . . . Lowery, K. (1996). 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. European Journal of Cancer Part A, 32(SUPPL. 5), 1945-1954.
Scopus171996 Cunningham, D., Zalcberg, J. R., Rath, U., Olver, I., VanCutsem, E., Svensson, C., . . . Lowery, K. (1996). 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia (Reprinted from European Journal of Cancer, vol 32A, pg 1945-1954, 1995). EUROPEAN JOURNAL OF CANCER, 32A, R1-+. 1995 Olver, I. N. (1995). An open label study of tropisetron for acute and delayed cisplatin-induced emesis. EUROPEAN JOURNAL OF CANCER, 31A, 1224. 1995 Zalcberq, J., Cunningham, D., Rath, U., Olver, I., Kerr, D., VanCutsem, E., . . . Harper, P. (1995). 'Tomudex' (ZD1694) has a higher response rate, significantly less leucopenia and mucositis and a simpler dosing regimen than 5-fluorouracil (5-FU) and leucovorin (LV) for advanced colorectal cancer (CRC): First results of a phase III study. EUROPEAN JOURNAL OF CANCER, 31A, 701. 1995 Phillips, K. A., Fitzharris, B., Friedlander, M., McCrystal, M., Olver, I., Joughin, J., . . . Smith, J. (1995). Australasian multicentre phase II study of paclitaxel (Taxol) in relapsed ovarian cancer. Australian and New Zealand Journal of Medicine, 25(4), 337-343.
Scopus15 WoS14 Europe PMC61995 Cunningham, D., Zalcberg, J. R., Rath, U., Olver, I., Van Cutsem, E., Svensson, C., . . . Lowery, K. (1995). 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. European Journal of Cancer, 31(12), 1945-1954.
Scopus137 WoS141 Europe PMC611995 Olver, I. N., Buchanan, L., Laidlaw, C., & Poulton, G. (1995). The adequacy of consent forms for informing patients entering oncological clinical trials. Annals of Oncology, 6(9), 867-870.
Scopus47 Europe PMC311995 Olver, I. N. (1995). Assessing the comparative clinical value of tropisetron. Australian and New Zealand Journal of Medicine, 25(5), 523-527.
WoS11995 Olver, I., Green, M., Peters, W., Zimet, A., Toner, G., Bishop, J., . . . Birkhofer, M. (1995). A phase II trial of zeniplatin in metastatic melanoma. American Journal of Clinical Oncology: Cancer Clinical Trials, 18(1), 56-58.
Scopus10 WoS8 Europe PMC51995 Olver, I. N., Webster, L. K., Millward, M. J., Stokes, K. H., & Bishop, J. F. (1995). A phase I and pharmacokinetics study of prolonged ambulatory-infusion carboplatin. Cancer Chemotherapy and Pharmacology, 37(1-2), 79-85.
Scopus14 WoS14 Europe PMC71995 Olver, I. N., Turrell, S. J., Olszewski, N. A., & Willson, K. J. (1995). Impact of an information and consent form on patients having chemotherapy. Medical Journal of Australia, 162(2), 82-83.
Scopus38 WoS32 Europe PMC201995 Basser, R., To, L., Begley, C., Juttner, C., Maher, D., Szer, J., . . . Green, M. (1995). Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells. Clinical Cancer Research, 1(7), 715-721.
Scopus38 WoS36 Europe PMC151994 Maher, D. W., Lieschke, G. J., Green, M., Bishop, J., Stuart-Harris, R., Wolf, M., . . . Morstyn, G. (1994). Filgrastim in patients with chemotherapy-induced febrile neutropenia: A double-blind, placebo-controlled trial. Annals of Internal Medicine, 121(7), 492-501.
Scopus218 WoS172 Europe PMC1071994 Bishop, J. F., Ball, D., Crennan, E., Ryan, G., Davis, S., Toner, G., . . . Olver, I. (1994). Radiation and carboplatin combined-modality therapy in non-small cell lung cancer.. Seminars in oncology, 21(3 Suppl 6), 91-96.
Europe PMC51994 Olver, I. N., Laidlaw, C. R., Matthews, J. P., Bishop, J. F., Hayes, A. M., Wolf, M., & Toner, G. C. (1994). A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapy. European Journal of Cancer, 30(4), 426-429.
Scopus6 WoS4 Europe PMC21994 Olver, I. N., Matthews, J. P., Bishop, J. F., & Smith, R. A. (1994). The roles of patient and observer assessments in anti-emetic trials. European Journal of Cancer, 30(9), 1223-1227.
Scopus14 WoS13 Europe PMC71994 OLVER, I. N. (1994). CONFRONTATIONS WITH THE REAPER - FELDMAN,F. BIOETHICS, 8(3), 279-281. 1994 Bishop, J., Ball, D., Crennan, E., Ryan, G., Davis, S., Toner, G., . . . Olver, I. (1994). Radiation and carboplatin combined-modality therapy in non-small cell lung cancer. Seminars in Oncology, 21(3 SUPPL. 6), 91-96.
Scopus71993 Olver, I. N., Sandeman, T. F., Laidlaw, C. R., Zimet, A. S., & Bishop, J. F. (1993). Oral methotrexate for superficial transitional cell carcinoma of the bladder. Journal of Urology, 149(5), 1006-1009.
Scopus2 WoS11993 Thomson, D. B., Adena, M., McLeod, G. R. C., Hersey, P., Gill, P. G., Coates, A. S., . . . Kingston, D. (1993). Interferon-α2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: Results of a multi-institutional Australian randomized trial. Melanoma Research, 3(2), 133-138.
Scopus130 WoS113 Europe PMC691993 Bishop, J. F., Smith, J. G., Jeal, P. N., Murray, R., Drummond, R. M., Pitt, P., . . . Bhowal, A. K. (1993). The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: A randomised double-blind placebo controlled trial. European Journal of Cancer, 29(6), 814-818.
Scopus9 WoS8 Europe PMC51993 Coates, A., Thomson, D., McLeod, G. R. M., Hersey, P., Gill, P. G., Olver, I. N., . . . Walpole, E. (1993). Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. European Journal of Cancer, 29(12), 1731-1734.
Scopus143 WoS128 Europe PMC821992 Olver, I. N. (1992). Antiemetic study design: desirable objectives, stratifications and analyses.. The British journal of cancer. Supplement, 19, S30-S34.
Scopus1 WoS12 Europe PMC31992 Olver, I. N., Bishop, J. F., Green, M., Zimet, A., & Laidlaw, C. (1992). A phase II study of cisplatinum and continuous infusion 5-fluorouracil for metastatic melanoma. American Journal of Clinical Oncology: Cancer Clinical Trials, 15(6), 503-505.
Scopus2 WoS2 Europe PMC11992 Rischin, D., Bishop, J. F., Olver, I. N., Laidlaw, C. R., Zimet, A., Jeal, P., & Dipell, J. F. (1992). A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer. American Journal of Clinical Oncology: Cancer Clinical Trials, 15(5), 392-394. 1992 Doig, R. G., Olver, I. N., Jeal, P. N., & Bishop, J. F. (1992). Symptomatic choroidal metastases in breast cancer. Australian and New Zealand Journal of Medicine, 22(4), 349-352.
Scopus6 WoS7 Europe PMC51992 Olver, I. N., Webster, L. K., Bishop, J. F., & Stokes, K. H. (1992). A phase I and pharmacokinetic study of 12-h infusion of flavone acetic acid. Cancer Chemotherapy and Pharmacology, 29(5), 354-360.
Scopus10 WoS13 Europe PMC61992 Olver, I. N. (1992). Methodology in anti-emetic trials. Oncology (Switzerland), 49(4), 269-272.
Scopus8 WoS6 Europe PMC31992 Olver, I. N., Wolf, M., Laidlaw, C., Bishop, J. F., Cooper, I. A., Matthews, J., . . . Buchanan, L. (1992). A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy. European Journal of Cancer, 28(11), 1798-1802.
Scopus24 WoS20 Europe PMC131992 Bishop, J., Murray, R., Webster, L., Pitt, P., Stokes, K., Fennessy, A., . . . Leber, G. (1992). Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer. Cancer Chemotherapy and Pharmacology, 30(3), 174-178.
Scopus26 WoS22 Europe PMC151992 Bishop, J. F., Matthews, J. P., Wolf, M. M., Oliver, I. N., Reynolds, S., Walpole, E., . . . Tan, L. G. (1992). A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy. European Journal of Cancer, 28(1), 47-50.
Scopus7 Europe PMC71992 Morrow, G. R., Cull, A., Grunberg, S., Smyth, J., Tyers, M. B., Gralla, R. J., . . . Olver, I. N. (1992). Behavioural factors influencing the development and expression of chemotherapy induced side effects. British Journal of Cancer, 66(SUPPL. 19), S54-S60.
Scopus29 Europe PMC41992 ROILA., SMYTH, J., BROWN., KOSLOW, W., TYERS., JURGENS., . . . AYA. (1992). ONDANSETRON - A NEW CONCEPT IN ANTIEMETIC THERAPY - PANEL DISCUSSION .1.. ONCOLOGY, 49(4), 286-287. 1992 Olver, I. N., Smyth, J., Morrow, G. R., Soukop, M., de Muller, P. H. M., Buxton, M. J., & Groshen, S. (1992). Antiemetic study design: Desirable objectives, stratifications and analyses. British Journal of Cancer, 66(SUPPL. 19).
Scopus141991 BALL, D., BISHOP, J., CRENNAN, E., & OLVER, I. (1991). Concurrent Radiotherapy and Carboplatin in Non Small‐Cell Lung Cancer: A Pilot Study Using Conventional and Accelerated Fractionation. Australasian Radiology, 35(1), 66-67.
Scopus8 Europe PMC61990 Olver, I. N., Reece, P. A., Bishop, J. F., Morris, R. G., Hillcoat, B. L., & Guentert, T. W. (1990). A phase I study of doxifluridine as a five-day stepped-dose continuous infusion. American Journal of Clinical Oncology: Cancer Clinical Trials, 13(4), 308-311.
Scopus3 WoS31990 Bishop, J. F., Kefford, R., Raghavan, D., Zalcberg, J., Stuart-Harris, R., Ball, D., . . . Zimet, A. (1990). Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer. Cancer Chemotherapy and Pharmacology, 25(5), 367-370.
Scopus15 WoS20 Europe PMC81990 Reece, P. A., Olver, I. N., Morris, R. G., Bishop, J. F., Guentert, T. W., Hill, H. S., & Hillcoat, B. L. (1990). Pharmacokinetic study of doxifluridine given by 5-day stepped-dose infusion. Cancer Chemotherapy and Pharmacology, 25(4), 274-278.
Scopus3 WoS31990 Olver, I. N., Pearl, P., Wiernik, P. H., & Aisner, J. (1990). SMALL BOWEL OBSTRUCTION AS A LATE COMPLICATION OF THE TREATMENT OF HODGKIN'S DISEASE. Australian and New Zealand Journal of Surgery, 60(8), 585-588.
Scopus3 WoS11989 Abrams, J. S., Tait, N., Silva, H., Eisenberger, M., Van Echo, D. A., Olver, I. N., & Aisner, J. (1989). Phase II trial of N-methylformamide in advanced renal cancer. American Journal of Clinical Oncology: Cancer Clinical Trials, 12(1), 41-42.
Scopus3 WoS5 Europe PMC11989 Olver, I. N., Webster, L. K., Bishop, J. F., Clarke, J., & Hillcoat, B. L. (1989). A dose finding study of prochlorperazine as an antiemetic for cancer chemotherapy. European Journal of Cancer and Clinical Oncology, 25(10), 1457-1461.
Scopus18 WoS17 Europe PMC91989 Olver, I. N., Dalley, D., Woods, R., Aroney, R., Hughes, P., Bishop, J. F., & Cruickshank, D. (1989). Carboplatin and continuous infusion 5-fluorouracil for advanced head and neck cancer. European Journal of Cancer and Clinical Oncology, 25(2), 173-176.
Scopus11 WoS10 Europe PMC61989 Hillcoat, B. L., Raghavan, D., Matthews, J., Kefford, R., Yuen, K., Woods, R., . . . McLennan, R. (1989). A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. Journal of Clinical Oncology, 7(6), 706-709.
Scopus82 WoS87 Europe PMC501989 Olver, I. N., Roos, I. A. G., Thomas, K., & Hillcoat, B. L. (1989). Development of a murine gastric distension model for testing the emetic potential of new drugs and efficacy of antiemetics. Chemico-Biological Interactions, 69(4), 353-357.
Scopus5 WoS6 Europe PMC41989 Bishop, J. F., Raghavan, D., Olver, I. N., Reece, P., Morris, R., & Friedlander, M. L. (1989). A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion. Cancer Chemotherapy and Pharmacology, 24(4), 246-250.
Scopus12 WoS12 Europe PMC61988 Olver, I. N., Wolf, M. M., Cruickshank, D., Worotniuk, V., Ding, J. C., Cooper, I. A., & Matthews, J. P. (1988). Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in hodgkin's disease. An analysis of long‐term follow‐up. Cancer, 62(2), 233-239.
Scopus31 WoS25 Europe PMC151988 Olver, I. N. (1988). The optimal management of cytotoxic-drug extravasation: solving the burning question.. The Medical journal of Australia, 149(9), 506-507.
Scopus2 WoS2 Europe PMC11988 Olver, I. N., Aisner, J., Hament, A., Buchanan, L., Bishop, J. F., & Kaplan, R. S. (1988). A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. Journal of Clinical Oncology, 6(11), 1732-1735.
Scopus103 WoS68 Europe PMC451987 OLVER, I. N., RAGHAVAN, D., BISHOP, J. F., MORSTYN, G., KEFFORD, R., STUARTHARRIS, R., . . . HILLCOAT, B. (1987). CARBOPLATIN AND VP16-213 WITH RADIOTHERAPY (RT) AS INITIAL TREATMENT FOR PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC). INVESTIGATIONAL NEW DRUGS, 5(1), 62. 1987 MORRIS, R. G., REECE, P. A., BISHOP, J. F., OLVER, I. N., & RAGHAVAN, D. (1987). PHASE-I PHARMACOKINETIC STUDY OF THE METHOTREXATE ANALOG, TRIMETREXATE, IN PATIENTS WITH ADVANCED CANCER. MEDICAL AND PEDIATRIC ONCOLOGY, 15(3), 124. 1987 OLVER, I. N., BISHOP, J. F., RAGHAVAN, D., REECE, P., & MORRIS, R. (1987). PHASE-I STUDY OF TRIMETREXATE (TMTX) AS A 5 DAY CONTINUOUS INFUSION. MEDICAL AND PEDIATRIC ONCOLOGY, 15(3), 151.
WoS21987 Reece, P. A., Bishop, J. F., Olver, I. N., Stafford, I., Hillocat, B. L., & Morstyn, G. (1987). Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma. Cancer Chemotherapy and Pharmacology, 19(4), 326-330.
Scopus33 WoS35 Europe PMC161987 OLVER, I. N., ROOS, I. A., THOMAS, K., & HILLCOAT, B. L. (1987). THE EFFECT OF ESCALATING DOSES OF PROCHLORPERAZINE ON CISPLATINUM (DDP) INDUCED GASTRIC DISTENSION IN MICE. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 28, 430. 1987 Reece, P. A., & Morris, R. G. (1987). Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer. Cancer Research, 47(11), 2996-2999.
Scopus21 WoS22 Europe PMC91987 Bishop, J. F., Raghavan, D., Stuart-Harris, R., Morstyn, G., Aroney, R., Kefford, R., . . . Fox, R. (1987). Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer. Journal of Clinical Oncology, 5(10), 1574-1578.
Scopus108 WoS93 Europe PMC531986 Olver, I. N. (1986). Should chemotherapy be standard treatment for non-small-cell lung cancer?. Medical Journal of Australia, 144(13), 675-676.
Scopus1 WoS2 Europe PMC11986 BISHOP, J. F., STUARTHARRIS, R., RAGHAVAN, D., OLVER, I., BALL, D., MORSTYN, G., . . . KEFFORD, R. (1986). CARBOPLATIN (CBDCA, JM8 VP16-213 IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC). AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 16(4), 621.
WoS21986 Olver, I. N., Donehower, R. C., van Echo, D. A., Ettinger, D. S., & Aisner, J. (1986). Phase II trial of carboplatin in non-small cell lung cancer. Cancer Treatment Reports, 70(3), 421-422.
Scopus41 WoS36 Europe PMC191986 Olver, I. N., Simon, R. M., & Aisner, J. (1986). Antiemetic studies: A methodological discussion. Cancer Treatment Reports, 70(5), 555-563.
Scopus72 WoS71 Europe PMC381985 WOLF, M. M., COOPER, I. A., OLVER, I. N., LIEW, K. H., DING, J. C., & MADIGAN, J. P. (1985). NON‐HODGKIN'S LYMPHOMA INVOLVING THE CENTRAL NERVOUS SYSTEM. Australian and New Zealand Journal of Medicine, 15(1), 16-21.
Scopus24 WoS23 Europe PMC101984 Bishop, J. F., Olver, I. N., Wolf, M. M., Matthews, J. P., Long, M., Bingham, J., . . . Cooper, I. A. (1984). Lorazepam: A randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine. Journal of Clinical Oncology, 2(6), 691-695.
Scopus49 WoS61 Europe PMC311983 OLVER, I. N., WOLF, M. M., BISHOP, J. F., DING, J. C., COOPER, I. A., & MATTHEWS, J. P. (1983). TREATMENT OF ADVANCED MOPP RESISTANT HODGKINS-DISEASE WITH ABVP. MEDICAL AND PEDIATRIC ONCOLOGY, 11(3), 215. 1983 OLVER, I. N., WOLF, M. M., BISHOP, J. F., DING, J. C., COOPER, I. A., & MATTHEWS, J. (1983). ADRIAMYCIN COMBINATIONS AS SALVAGE THERAPY IN ADVANCED MOPP‐RESISTANT HODGKIN'S DISEASE. Australian and New Zealand Journal of Medicine, 13(4), 369-373.
Scopus3 WoS1 Europe PMC31983 Olver, I. N., & Schwarz, M. A. (1983). Use of dimethyl sulfoxide in limiting tissue damage caused by extravasation of doxorubicin. Cancer Treatment Reports, 67(4), 407-408.
Scopus29 WoS28 Europe PMC161983 Olver, I. N., Schwarz, M. A., Westmore, D. D., & Masterton, J. P. (1983). COMPLETE REMISSION IN EXTRAGONADAL SEMINOMA PRIMARILY TREATED WITH CHEMOTHERAPY AND RESTAGED BY RETROPERITONEAL NODAL DISSECTION. Australian and New Zealand Journal of Surgery, 53(3), 277-280.
Scopus1 Europe PMC11980 Olver, I. N., Jennings, G. L., Bobik, A., & Esler, M. (1980). Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension. British Medical Journal, 281(6235), 275-276.
Scopus18 WoS12 Europe PMC10 -
Books
Year Citation 2013 Olver, I. (2013). Investigating prayer: impact on health and quality of life (Vol. 9781461445715). United States: Springer.
Scopus82011 Olver, I., & Robotin, M. (Eds.) (2011). Perspectives on complementary and alternative medicines. IMPERIAL COLLEGE PRESS.
Scopus12011 Olver, I., & Robotin, M. (Eds.) (2011). Perspectives on complementary and alternative medicines. IMPERIAL COLLEGE PRESS.
Scopus12011 Olver, I. N. (Ed.) (2011). The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer US.
2009 Robotin, M., Olver, I., & Girgis, A. (2009). When cancer crosses disciplines: A physician’s handbook. PUBLISHED BY IMPERIAL COLLEGE PRESS AND DISTRIBUTED BY WORLD SCIENTIFIC PUBLISHING CO..
2002 Olver, I. (2002). Is death ever preferable to life?. PO Box 17, 3300 AA Dordrecht, The Netherlands: Kluwer Academic Publishers. -
Book Chapters
Year Citation 2022 Ward, P., Foley, K., Meyer, S., Thomas, J., Huppatz, E., Olver, I., . . . Lunnay, B. (2022). Uncertainty, Fear and Control During COVID-19 … or … Making a Safe Boat to Survive Rough Seas: The Lived Experience of Women in South Australia During Early COVID-19 Lockdowns. In P. Brown, & J. Zinn (Eds.), Covid-19 and the Sociology of Risk and Uncertainty Studies of Social Phenomena and Social Theory Across 6 Continents (pp. 167-190). Springer Nature.
2022 Olver, I. (2022). Interpretation of Investigations. In Orofacial Supportive Care in Cancer: A Contemporary Oral Oncology Perspective (pp. 239-254). Springer International Publishing.
2022 Olver, I. (2022). Solid Tumours and Update on Modern Medical Oncology Interventions. In Orofacial Supportive Care in Cancer: A Contemporary Oral Oncology Perspective (pp. 23-38). Springer International Publishing.
2011 Olver, I. N. (2011). Antinausea medications. In Cancer Chemotherapy and Biotherapy: Principles and Practice (pp. 1696-1717). 2011 Olver, I. N. (2011). Should spirituality and prayer be part of complementary therapies?. In Perspectives on Complementary and Alternative Medicines (pp. 143-156). IMPERIAL COLLEGE PRESS.
2011 Olver, I. N. (2011). Complementary and alternative medicines — The introductory perspective. In Perspectives on Complementary and Alternative Medicines (pp. 1-12). IMPERIAL COLLEGE PRESS.
2009 Olver, I. N. (2009). Diagnostic dilemmas during and after chemotherapy treatment. In When Cancer Crosses Disciplines: A Physician's Handbook (pp. 161-178). PUBLISHED BY IMPERIAL COLLEGE PRESS AND DISTRIBUTED BY WORLD SCIENTIFIC PUBLISHING CO..
2005 Olver, I. (2005). Bioethical implications of hope. In J. Eliott (Ed.), Interdisciplinary Perspectives on Hope (pp. 241-256). New York: Nova Science Publishers. 2004 Ramshaw, H., Hercus, T., Olver, I., & Lopez, A. (2004). Potential for hematopoietics growth factor antagonists in oncology. In G. Mostyn, M. Foote, & G. Lieschke (Eds.), Hematopoietic growth factors in oncology: Basic science and clinical therapeutics (pp. 447-465). 999 Riverview Drive, Suite 208, Totowa, NJ 07512, USA: Humana Press.
-
Conference Papers
Year Citation 2023 Bowden, J. A., Bartram, A., Harrison, N. J., Norris, C. A., Pettigrew, S., Room, R., . . . Bowshall, M. (2023). Understanding Australian parents' supply of alcohol to adolescents: A national survey guided by the theory of planned behaviour. In DRUG AND ALCOHOL REVIEW Vol. 42 (pp. S45-S46). WILEY. 2023 Bartram, A., Harrison, N. J., Norris, C. A., Kim, S., Pettigrew, S., Room, R., . . . Bowden, J. A. (2023). Parents' perceptions and intentions to provide zeroalcohol beverages to adolescents. In DRUG AND ALCOHOL REVIEW Vol. 42 (pp. S37). WILEY. 2023 Mersiades, A., Kirby, A., Stockler, M. R., Tognela, A., Olver, I. N., Morton, R. L., . . . Grimison, P. S. (2023). Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial. In JOURNAL OF CLINICAL ONCOLOGY Vol. 41 (pp. 1 page). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. 2023 Ostwal, V. S., Mandavkar, S., Parulekar, M., Ramaswamy, A., Bhargava, P. G., Srinivas, S., . . . Olver, I. N. (2023). Olanzapine for the prevention of chemotherapy induced nausea vomiting in patients receiving moderately emetogenic chemotherapeutic (MEC) regimens: Results of a prospective triple blinded phase III multicentric study (OMEC). In ANNALS OF ONCOLOGY Vol. 34 (pp. S1336). SPAIN, Barcelona: ELSEVIER.
2022 Norris, C. A., Harrison, N. J., Bartram, A., Murphy, M., Room, R., Pettigrew, S., . . . Bowden, J. (2022). Influences on parental alcohol supply and non-supply decisions - Qualitative insights. In DRUG AND ALCOHOL REVIEW Vol. 41 (pp. S103-S104). WILEY. 2022 Harrison, N. J., Norris, C. A., Bartram, A., Murphy, M., Pettigrew, S., Dell, A., . . . Bowden, J. (2022). "It works like a gateway drug. they start on the zero alcohol and they want to try the real thing": Perceptions of zero-alcohol beverages and their use by adolescents. In DRUG AND ALCOHOL REVIEW Vol. 41 (pp. S70-S71). WILEY. 2022 van der Kruk, S. R., Harrison, N. J., Bartram, A., Newton, S., Miller, C., Bowshall, M., . . . Bowden, J. (2022). Prevalence of parental supply of alcohol to children and adolescents: A systematic review of international studies. In DRUG AND ALCOHOL REVIEW Vol. 41 (pp. S141). WILEY. 2021 Mersiades, A., Tognela, A., Kirby, A., Stockler, M., Lintzeris, N., Simes, J., . . . Grimison, P. (2021). Definitive randomised double-blind placebo-controlled trial evaluating an oral cannabinoid-rich THC/CBD cannabis extract for chemotherapy-induced nausea and vomiting (CINV): Trial in progress. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 17 (pp. 203-204). WILEY. 2021 Bowden, J., Harrison, N. J., Caruso, J., Room, R., Pettigrew, S., Olver, I., & Miller, C. (2021). WHICH DRINKERS CHANGE THEIR ALCOHOL CONSUMPTION DUE TO ENERGY CONTENT CONCERNS?. In DRUG AND ALCOHOL REVIEW Vol. 40 (pp. S50). WILEY. 2021 Robin, R., Bowden, J., Crabb, S., Wilson, S., Harrison, N. J., Bartram, A., . . . Miller, C. (2021). Symposium: alcohol and drug use in Australia: a comprehensive policy approach informed by evidence and experts to reduce harms. In Proceedings of the APSAD Scientific Alcohol and Drug Conference as published in Drug and Alcohol Review Vol. 40 (pp. S33). online: Wiley.
2021 Bowden, J., Crabb, S., Wilson, S., Harrison, N. J., Bartram, A., Vanderkruk, S., . . . Room, R. (2021). POLICY RECOMMENDATIONS TO REDUCE HARMS FROM ALCOHOL. In DRUG AND ALCOHOL REVIEW Vol. 40 (pp. S33). WILEY. 2021 Bowden, J., Harrison, N. J., Bartram, A., Murphy, M., Room, R., Pettigrew, S., . . . Miller, C. (2021). "I think we'd try and delay it, and try and deflect it or wait for another day": parental views about supply of alcohol to adolescents. In Proceedings of the APSAD Scientific Drug and Alcohol Conference, as published in Drug and Alcohol Review Vol. 40 (pp. S49-S50). online: Wiley.
2021 Kima, G. Y., Chonga, C. Y., Baenzigerc, O., Conduit, C., Lewin, J., Taylor, M., . . . Tran, B. (2021). Hypogonadism and Obesity in Australian Testicular Cancer Survivors (TCS). In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 17 (pp. 55-56). WILEY. 2020 Grimison, P. S., Stockler, M. R., Kirby, A., Walsh, A., Lintzeris, N., Cheung, Y., . . . Della-Fiorentina, S. (2020). Results of crossover phase 2 component of randomised placebo-controlled trial evaluating oral THC/CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV). In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 16 (pp. 206-207). WILEY. 2018 Whitford, H., Salsman, J., & Olver, I. (2018). Quality of life, spiritual well-being, and self-compassion: finding 'peace of mind' among cancer survivors. In QUALITY OF LIFE RESEARCH Vol. 27 (pp. S46). SPRINGER. 2018 Mersiades, A., Tognela, A., Haber, P. S., Stockler, M., Lintzeris, N., Simes, J., . . . Grimison, P. (2018). Pilot and Definitive Randomised Double-Blind Placebo-Controlled Trials Evaluating an Oral Cannabinoid-Rich THC/CBD Cannabis Extract for Chemotherapy-Induced Nausea and Vomiting (CINV). In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 14 (pp. 66). WILEY. 2018 Miller, E., Ward, P., Olver, I., Meyer, S., McNaughton, D., Mwanri, L., . . . Macdonald, S. (2018). Communicating messages about alcohol-related BC risk: the Alcohol and Breast Cancer (ABC) study. In BRITISH JOURNAL OF CANCER Vol. 119 (pp. 33). Glasgow, SCOTLAND: NATURE PUBLISHING GROUP. 2018 Ross, X. S., Fennell, K., Olver, I., & Patterson, P. (2018). Designing a Smartphone Self-Management Program for Cancer Patients Taking Oral Chemotherapy; Patients' Preferences on Structure and Delivery. In PSYCHO-ONCOLOGY Vol. 27 (pp. 216-217). WILEY. 2018 Fennell, K. M., Ross, X. S., & Olver, I. (2018). Rural cancer stories: The power of online, video-based, peer-directed information and support. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 14 (pp. 134). WILEY. 2016 Olver, I. N., Whitford, H. S., Kalinowski, P., Schembri, A., Toner, G. C., Stockler, M. R., . . . Grimison, P. S. (2016). Chemotherapy and cognitive function in testicular cancer: A prospective, longitudinal cohort study. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34 (pp. 2 pages). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.
WoS12013 Olver, I. N., Von Dincklage, J., Holliday, L., & Vuletich, C. (2013). WIKI-BASED TREATMENT GUIDELINES FOR LUNG CANCER. In JOURNAL OF THORACIC ONCOLOGY Vol. 8 (pp. S173-S174). LIPPINCOTT WILLIAMS & WILKINS. 2012 Olver, I. N., Eliott, J. A., & Koczwara, B. (2012). A qualitative study of the subjective experience of chemotherapy-induced nausea in cancer patients and survivors.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 30 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. 2011 Olver, I. N., & Eliott, J. A. (2011). A Qualitative Study of Survivorship Issues in the Families of Patients With Cancer. In EUROPEAN JOURNAL OF CANCER Vol. 47 (pp. S230). Stockholm, SWEDEN: ELSEVIER SCI LTD.
2010 Koczwara, B., Francis, K., Marine, F., Goldstein, D., Underhill, C., & Olver, I. (2010). Reaching further with online education? the development of an effective online program in palliative oncology. In Journal of Cancer Education Vol. 25 (pp. 317-323). Sydney, AUSTRALIA: SPRINGER.
Scopus21 WoS20 Europe PMC122009 Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gurney, H., . . . Toner, G. C. (2009). Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: Updated analysis of a randomized trial with 8 years follow-up. In JOURNAL OF CLINICAL ONCOLOGY Vol. 27 (pp. 2 pages). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
WoS22009 Olver, I. N., & Whitford, H. S. (2009). A randomized controlled trial of the effect of intercessory prayer on the spiritual wellbeing and quality of life of patients with cancer. In JOURNAL OF CLINICAL ONCOLOGY Vol. 27 (pp. 2 pages). Orlando, FL: AMER SOC CLINICAL ONCOLOGY. 2009 Olver, I., & Whitford, H. (2009). Intercessory prayer improves spiritual wellbeing in a randomised controlled trial in patients with cancer. In EJC SUPPLEMENTS Vol. 7 (pp. 176). Berlin, GERMANY: PERGAMON-ELSEVIER SCIENCE LTD.
2009 Van Hazel, G. A., Pavlakis, N., Goldstein, D., Olver, I. N., Tapner, M. J., Price, D., . . . George, J. (2009). Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. In Journal of Clinical Oncology Vol. 27 (pp. 4089-4095). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Scopus118 WoS105 Europe PMC772008 Yeoh, E., Di Matteo, A. C., Botten, R. J., Butters, J., Dhillon, V., Holloway, R. H., . . . Fenech, M. (2008). Cytokinesis blocked micronucleus (Cbmn) assay is predictive of gastrointestinal (GI) sequeale 2 years following radiation therapy (AT) for prostate carcinoma (CAP) whilst micronutrients reduce their severity. In GASTROENTEROLOGY Vol. 134 (pp. A65). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC.
WoS12007 Yeoh, E., Di Matteo, A., Botten, R., Butters, J., Salisbury, C., Dhillon, V., . . . Fenech, M. (2007). Baseline cytokinesis blocked micronucleus (CBMN) index correlates with gastrointestinal sequelae including anal sphincter morphology 1 year after radiation therapy (RT) for carcinoma of the prostate (CAP). In GASTROENTEROLOGY Vol. 132 (pp. A590). Washington, DC: W B SAUNDERS CO-ELSEVIER INC.
WoS12007 Koczwara, B., Ackland, S., Esterman, A., Marine, F., Stockler, M., & Olver, I. (2007). The impact of Australia Asia Pacific Clinical Oncology Research Development (ACORD) on research productivity of participants according to region of origin. In JOURNAL OF CLINICAL ONCOLOGY Vol. 25 (pp. 2 pages). AMER SOC CLINICAL ONCOLOGY. 2007 Olver, I. N., & Whitford, H. S. (2007). Using an interactive CD-ROM to gain informed consent for chemotherapy: Attempting to improve patient anxiety and depression during treatment. In JOURNAL OF CLINICAL ONCOLOGY Vol. 25 (pp. 1 page). AMER SOC CLINICAL ONCOLOGY. 2007 Olver, I. N., & Whitford, H. S. (2007). A randomized trial of written information versus an interactive multimedia CD-ROM for improving informed consent to chemotherapy. In EJC SUPPLEMENTS Vol. 5 (pp. 143). Barcelona, SPAIN: PERGAMON-ELSEVIER SCIENCE LTD.
2006 Di Matteo, A. C., Botten, R. J., Butters, J. F., Fenech, M., Olver, I., & Yeoh, E. (2006). The cytokinesis blocked micronucleus assay correlates with acute anorectal dysfunction after radiation therapy (RT) for carcinoma of the prostate and may predict individual radiosensitivity. In GASTROENTEROLOGY Vol. 130 (pp. A726). Los Angeles, CA: W B SAUNDERS CO-ELSEVIER INC. 2005 Di Matteo, A. C., Botten, R., Tamblyn, D., Fenech, M., Olver, I., & Yeoh, E. (2005). Micronutrients may reduce GI morbidity following radiation therapy for prostate carcinoma. In GASTROENTEROLOGY Vol. 128 (pp. A265). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. 2005 Olver, I., Borg, M., Pittman, K., Karapetis, C., & Jurisevic, C. (2005). A pilot study of celecoxib with docetaxel/radiation and consolidation docetaxel/cisplatin in inoperable stage IIIa and IIIb non-small cell lung cancer (NSCLC). In LUNG CANCER Vol. 49 (pp. S392). Barcelona, SPAIN: ELSEVIER IRELAND LTD.
WoS12005 Goldstein, D., van Hazel, G., Pavlakis, N., & Olver, I. (2005). Selective internal radiation therapy (SIRT) plus systemic chemotherapy with irinotecan. A phase I dose escalation study. In JOURNAL OF CLINICAL ONCOLOGY Vol. 23 (pp. 296S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
WoS32005 Olver, I. N., Selva-Nayagam, S., Fried, O., Davy, M., & Barton, M. B. (2005). Some of us know some things and some of us know others - Reducing the impact of cancer care on Aboriginal and Torres Strait Islander communities. In Cancer Forum Vol. 29 (pp. 10-13). AUSTRALIAN CANCER SOC INC.
Scopus5 WoS42005 Olver, I. N., & Eliott, J. A. (2005). Changes in cancer patients' perceptions of do-not-resuscitate orders as end of life (EOL) approaches. In JOURNAL OF CLINICAL ONCOLOGY Vol. 23 (pp. 747S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY. 2005 Pittman, K. B., Olver, I. N., Karapetis, C. S., Kotasek, D., Price, T. J., Patterson, W. K., . . . Greer, D. (2005). Mulicenter phase II study of gemcitabine and carboplatin combination therapy for patients with metastatic carcinoma of unknown primary site: final results.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 23 (pp. 764S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
WoS12004 Olver, I. N., & Eliott, J. A. (2004). Analysis of the speech of dying patients with cancer on end-of-life decision making. In JOURNAL OF CLINICAL ONCOLOGY Vol. 22 (pp. 782S). New Orleans, LA: AMER SOC CLINICAL ONCOLOGY. 1998 Morrow, G. R., Ballatori, E., Groshen, S., & Olver, I. (1998). Statistical considerations in the design, conduct and analyses of antiemetic clinical trials. An emerging consensus. In Supportive Care in Cancer Vol. 6 (pp. 261-265). PERUGIA, ITALY: SPRINGER.
Scopus3 WoS1 Europe PMC11997 Bishop, J., Dewar, J., Toner, G., Tattersall, M., Olver, I., Ackland, S., . . . Stephenson, J. (1997). Paclitaxel as first-line treatment for metastatic breast cancer. In ONCOLOGY Vol. 11 (pp. 19-23).
Scopus251997 Bishop, J., Dewar, J., Toner, G., Tattersall, M., Olver, I., Ackland, S., . . . Stephenson, J. (1997). A randomized study of paclitaxel versus cyclophosphamide/methotrexate/- fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results. In Seminars in Oncology Vol. 24.
Scopus121996 VanCutsem, E., Cunningham, D., Zalcberg, J., Rath, U., Olver, I. N., Kerr, D., . . . Azab, M. (1996). Final results and survival data of a large randomised trial of 'ZD1694' in advanced colorectal cancer (ACC) confirm comparable efficacy to 5-fluorouracil plus leucovorin (5FU+LV).. In GASTROENTEROLOGY Vol. 110 (pp. A608). W B SAUNDERS CO-ELSEVIER INC. 1994 To, L. B., Basser, R. L., Olver, I., Begley, C. G., Gill, P. G., Malycha, P., . . . Juttner, C. A. (1994). Multiple cycles of sub-maximal high-dose therapy and peripheral blood rescue for poor prognosis breast carcinoma. In Bone Marrow Transplantation Vol. 14.
Scopus1 -
Conference Items
Year Citation 2023 Norris, C. A., Harrison, N. J., Bartram, A., Pettigrew, S., Murphy, M., Miller, C., . . . Bowden, J. A. (2023). "It's very much about you as a role model, and your responsibilities as a parent": Parents' perspectives on adolescent alcohol provision messaging. Poster session presented at the meeting of Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference (APSAD 2023), as published in Drug and Alcohol Review. Adelaide, SA: Wiley.
2022 Lunnay, B., Foley, K., Warin, M., Wilson, C., Olver, I., Meyer, S. B., & Ward, P. R. (2022). Leveraging sober curiosity to support affluent midlife women towards alcohol reduction. Poster session presented at the meeting of Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference (APSAD 2022), as published in Drug and Alcohol Review. virtual online & Darwin: Wiley.
2021 Wilson, S., Bowden, J., Crabb, S., Harrison, N. J., Bartram, A., Vanderkruk, S., . . . Room, R. (2021). ALCOHOL AND OTHER DRUG USE AMONG ABORIGINAL AND TORRES STRAIT ISLANDER COMMUNITIES: POLICY RESPONSES TO REDUCE HARMS. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY. 2020 Olver, I. N., Gunn, K. M., Knott, V. E., Chong, A., Spronk, K., & Cunningham, J. (2020). Communicating cancer and its treatment to Australian Aboriginal patients with cancer: A qualitative study. Poster session presented at the meeting of Abstracts of the Annual Meeting of the American Society of Clinical Oncology (ASCO, 2020) as published in Journal of Clinical Oncology. Virtual Online: LIPPINCOTT WILLIAMS & WILKINS.
2020 Grimison, P. S., Stockler, M. R., Kirby, A., Walsh, A., Lintzeris, N., Cheung, Y., . . . Della-Fiorentina, S. (2020). Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. ELECTR NETWORK: LIPPINCOTT WILLIAMS & WILKINS. 2019 Olver, I., Gunn, K., Knott, V., Chong, A., Cominos, N., & Cunningham, J. (2019). Improving communication between health professionals and Aboriginal and Torres Strait Islander people who have been diagnosed with cancer. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY. 2019 Ross, X. S., Gunn, K. M., Patterson, P., & Olver, I. (2019). Development and proof-of-concept trial of a smartphone-based program to support oral chemotherapy adherence in young and adult cancer patients. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY. 2018 Mersiades, A., Tognela, A., Haber, P., Stockler, M. R., Lintzeris, N., McGregor, I., . . . Grimison, P. S. (2018). Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV). Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
2018 Olver, I., Carey, M., Boyes, A., Hall, A., Bryant, J., Walsh, J., & Sansom-Fisher, R. (2018). The timeliness of patients reporting the side effects of chemotherapy. Poster session presented at the meeting of Abstracts of the Medical Oncology Group of Australia’s 2018 Annual Scientific meeting: New Directions in Personalised Cancer Therapy (MOGA ASM 2018), as published in Asia-Pacific Journal of Clinical Oncology. Adelaide, South Australia: Wiley.
2018 Mersiades, A., Tognela, A., Haber, P., Stockler, M., Lintzeris, N., Simes, J., . . . Grimison, P. (2018). Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV). Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY. 2018 Mersiades, A., Tognela, A., Haber, P. S., Stockler, M., Lintzeris, N., Simes, J., . . . Grimison, P. (2018). Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV). Poster session presented at the meeting of Annals of oncology : official journal of the European Society for Medical Oncology. Munich, GERMANY: OXFORD UNIV PRESS.
Scopus1 WoS12017 Mersiades, A., Haber, P., Stockler, M., Lintzeris, N., Simes, J., McGregor, I., . . . Grimison, P. (2017). Pilot and Definitive Randomized Double-Blind Placebo-Controlled Trials Evaluating an Oral Cannabinoid-Rich THC/CBD Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV). Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY. 2017 Mersiades, A., Tognela, A., Haber, P., Stockler, M., Lintzeris, N., Simes, J., . . . Grimison, P. (2017). Pilot and Definitive Randomised Double-Blind Placebo-Controlled Trials Evaluating an Oral Cannabinoid-Rich THC/CBD Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV). Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY. 2017 Olver, I. N. (2017). Using Education to Disseminate and Implement Guidelines. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY. 2016 Koczwara, B., Freegard, S., Olver, I., Fallon-Ferguson, J., Knott, V., Christensen, C., & Ward, P. (2016). WORKAFTERCANCER.COM.AU - AN ONLINE RESOURCE TO SUPPORT CANCER SURVIVORS. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2016 Koczwara, B., Kemp, E., Freegard, S., Bareham, M., Olver, I., Fallon-Ferguson, J., . . . Knott, V. (2016). WORK AFTER CANCER - A QUALITATIVE STUDY OF SURVIVORS AND HEALTH CARE PROVIDERS. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2016 Olver, I., & Koczwara, B. (2016). OVERVIEW OF RETURNING TO WORK AFTER CANCER. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2016 Whitford, H., & Olver, I. (2016). 'THE HOPEFUL AND THE RESILIENT': A BIO-PSYCHO-SOCIAL-SPIRITUAL CANCER AND NON-CANCER PERSPECTIVE. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE. SPRINGER. 2016 Butow, P., Heiniger, L., Smith, A., Olver, I., Grimison, P., Klein, B., . . . Gurney, H. (2016). AN E-INTERVENTION FOR MEN AFTER TESTICULAR CANCER: FEASIBILITY AND ACCEPTABILITY TESTING. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE. SPRINGER. 2016 Grimison, P., Whitford, H. S., Kalinowski, P., Schembri, A., Toner, G., Stockler, M., . . . ANZUP Cancer Trials Group. (2016). A prospective, longitudinal cohort study to investigate the impact of chemotherapy on cognition in testicular cancer. Poster session presented at the meeting of Asia-Pacific Journal Of Clinical Oncology. Surfers Paradise, Old.: Wiley.
2016 Chittem, M., Eliott, J., & Olver, I. (2016). End-of-life decision-making in India. Poster session presented at the meeting of PSYCHO-ONCOLOGY. WILEY-BLACKWELL. 2016 Fennell, K., Bamford, L., Olver, I., & Wilson, C. (2016). Good systems not good luck: what oncologists and haematologists believe would make it easier for them to refer their patients to psychosocial care. Poster session presented at the meeting of PSYCHO-ONCOLOGY. WILEY-BLACKWELL. 2016 Stockler, M., Whitford, H. S., Kalinowski, P., Schembri, A., Toner, G., Grimison, P., . . . Olver, I. (2016). A prospective, longitudinal cohort study to investigate the impact of chemotherapy on cognition in testicular cancer. Poster session presented at the meeting of Asia-Pacific Journal Of Clinical Oncology. Brisbane, Qld.: Wiley.
2016 Toner, G. C., Whitford, H. S., Kalinowski, P., Grimison, P. S., Stockler, M. R., Martin, A. J., . . . Olver, I. N. (2016). The impact of chemotherapy on cognition: A longitudinal study in testicular cancer.. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. San Francisco, CA: AMER SOC CLINICAL ONCOLOGY.
2015 Olver, I. N., & Whitford, H. S. (2015). RARE AND UNCOMMON CANCERS: IMPACT ON QUALITY OF LIFE, PSYCHOLOGICAL MORBIDITY, AND USE OF CAMS. Poster session presented at the meeting of Asia-Pacific Journal of Clinical Oncology. WILEY-BLACKWELL. 2015 Smith, A. B., Heiniger, L., Butow, P., Grimison, P., Klein, B., Wootten, A., . . . Olver, I. (2015). e-TC: development and pilot testing of an online psychosocial intervention to reduce anxiety and depression in testicular cancer survivors. Poster session presented at the meeting of PSYCHO-ONCOLOGY. WILEY-BLACKWELL. 2015 Whitford, H. S., & Olver, I. (2015). The newly derived four-factor structure of the FACIT-Sp-Ex: comparing cancer survivors to other cancer/community groups. Poster session presented at the meeting of QUALITY OF LIFE RESEARCH. SPRINGER. 2015 Marshall, A. J., knott, V., Emery, J., Ward, P., Fallon-Ferguson, J., Olver, I., . . . Bareham, M. (2015). Supporting People with Cancer Return to Work in Disadvantaged Communities. Poster session presented at the meeting of Survivorship Conference. 2015 Smith, A. B., Heiniger, L., Butow, P., Grimison, P., Klein, B., Wootten, A., . . . Olver, I. (2015). E-TC: DEVELOPMENT AND PILOT TESTING OF AN ONLINE PSYCHOLOGICAL INTERVENTION FOR TESTICULAR CANCER SURVIVORS. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. Sydney, AUSTRALIA: WILEY. 2014 Heiniger, L., Butow, P., Olver, I., Grimison, P., Smith, A. B., Klein, B., . . . Gurney, H. (2014). e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer. Poster session presented at the meeting of Asia-Pacific Journal Of Clinical Oncology. Melbourne, Vic.: Wiley.
2014 Mellish, V., Wright, J., & Olver, I. (2014). LICENSED PRODUCTS GENERATE INCOME, INCREASE BRAND AWARENESS AND PROVIDE EDUCATION OPPORTUNITIES. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2014 Byrnes, M., McKiernan, S., Quin, N., Staal, K., Chapman, K., Bartlett, J., . . . Lavery, M. (2014). CANCER COUNCIL HELPLINE 13 11 20-HOW MANY PEOPLE USE THIS INFORMATION AND SUPPORT SERVICE AND WHY NOT?. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2014 Olver, I. (2014). LUNG CANCER: BUTT OUT OR SCREEN?. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2014 Heiniger, L., Butow, P., Olver, I., Grimison, P., Ben Smith, A., Klein, B., . . . Gurney, H. (2014). e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer. Poster session presented at the meeting of Asia-Pacific Journal Of Clinical Oncology. Melbourne, Vic.: Wiley.
2014 Isaac, R., Biswajit, P., Olver, I., Finkel, M., & Trevena, L. (2014). THE EFFECT OF A VOICE-SITE ON INFORMED CHOICE FOR WOMEN CONSIDERING CERVICAL CANCER SCREENING IN RURAL INDIA: A PHASE II CONTROLLED TRIAL. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2014 Isaac, R., Annie, I. K., Prashanth, H. R., Trevena, L., Olver, I., & Finkel, M. (2014). THE OUTCOME OF CERVICAL CANCER SCREENING SERVICES INTEGRATED WITH PRIMARY HEALTH CARE: DOWN STAGING CERVICAL CANCER IN A RESOURCE POOR SETTING. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2014 Olver, I. (2014). POST TESTICULAR CANCER TREATMENT COGNITION - CLEARING THE FOG. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2014 Olver, I. N., & Whitford, H. S. (2014). The importance of spiritual wellbeing domains in quality of life assessment: replicating and extending evidence of clinical utility. Poster session presented at the meeting of Asia-Pacific Journal Of Clinical Oncology. Sydney, N.S.W.: Wiley.
2014 Whitford, H. S., & Olver, I. N. (2014). The clinical and research implications of peace as part of spiritual wellbeing assessment in quality of life in cancer. Poster session presented at the meeting of Asia-Pacific Journal Of Clinical Oncology. Melbourne, Vic.: Wiley.
2014 Flight, I., Wilson, C., Zajac, I., Bastiaans, K., Turnbull, D., Young, G., & Olver, I. (2014). WHAT IS THE BEST WAY TO ORGANISE ONLINE COLORECTAL CANCER INFORMATION?. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2014 Wilson, C., Flight, I., Zajac, I., Turnbull, D., Young, G., & Olver, I. (2014). WHAT DO PEOPLE WANT TO KNOW ABOUT COLORECTAL CANCER AND WHAT IS THE BEST WAY TO ORGANISE THE INFORMATION THEY WANT?. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2013 Olver, I. N., von Dincklage, J., Garrett, A., Holliday, L., & Vuletich, C. (2013). Keeping guidelines current: A six-month evaluation of Wiki-based lung cancer guidelines.. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
WoS12013 von Dincklage, J., Olver, I., Garrett, A., Holliday, L., & Vuletich, C. (2013). DEVELOPING WIKI-BASED CLINICAL PRACTICE GUIDELINES FOR CANCER. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL.
WoS12013 Smith, A. B., King, M., Butow, P., Luckett, T., Grimison, P., Toner, G., . . . Olver, I. (2013). The Prevalence and Correlates of Supportive Care Needs in Testicular Cancer Survivors: A Cross- Sectional Study. Poster session presented at the meeting of PSYCHO-ONCOLOGY. WILEY-BLACKWELL. 2013 Best, M., Butow, P., & Olver, I. (2013). Spiritual Needs of Patients and the Role of Doctors in Meeting Them. Poster session presented at the meeting of PSYCHO-ONCOLOGY. WILEY-BLACKWELL. 2013 Aldridge, L., Best, M., Butow, P., Price, M., Zorbas, H., Webster, F., & Olver, I. (2013). Suffering in Cancer - Conceptualization, Assessment and Interventions. A Systematic Literature Review. Poster session presented at the meeting of PSYCHO-ONCOLOGY. WILEY-BLACKWELL. 2012 Olver, I. (2012). PERSPECTIVES ON COMPLEMENTARY AND ALTERNATIVE MEDICINES (CAM). Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2012 Best, M., Aldridge, L., Butow, P., Price, M., Zorbas, H., Webster, F., & Olver, I. (2012). SUFFERING IN CANCER - CONCEPTUALIZATION, ASSESSMENT AND INTERVENTIONS. A SYSTEMATIC LITERATURE REVIEW. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2012 Olver, I. (2012). CHEMOTHERAPY-COGNITION STUDY UPDATE. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL.
WoS22012 Klafke, N., Eliott, J., Olver, I., & Wittert, G. (2012). MEN WITH CANCER USING COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM): VARIATIONS IN SIGNIFICANT OTHERS' INVOLVEMENT. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL.
WoS22012 Fournier, M., Grimison, P., Stockler, M., Whitford, H., Toner, G., Thomson, D., . . . Olver, I. (2012). LOWER LEVELS OF SERUM TESTOSTERONE, QUALITY OF LIFE, AND TREATMENT FOR TESTICULAR CANCER: A PROSPECTIVE COHORT STUDY. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2011 Thaker, D. A., Sabesan, S. S., Van Houts, B., Bryett, A., & Olver, I. N. (2011). Tele Oncology Clinics in Rural Australia: a Cost-effective Cancer Care Model. Poster session presented at the meeting of EUROPEAN JOURNAL OF CANCER. Stockholm, SWEDEN: ELSEVIER SCI LTD.
2000 Olver, I., Vadas, M., Lopez, A., Keefe, D., Taylor, A., Brown, M., & To, L. (2000). A phase 1 study of the GM-CSF antagonist E21R. Poster session presented at the meeting of Proceedings of ASCO - Volume 19 2000. USA: American Society of Clinical Oncology.
| Period | Grant / Funding Title | Total Value |
|---|---|---|
| 2020 | Hospital Research Foundation SA HN-RHLN - Aboriginal Cancer Healing Centres – facilitation to expand the roles and capabilities of existing cancer services | $49,680 |
| 2019 | ARC Discovery Project DP190103434 - Understanding middle-aged women’s responses to alcohol/breast cancer risks | $460,000 |
| 2019 | Research Themes Investment Scheme Grant (RTIS), University of South Australia - Choice experiments aiming to optimize the response to financial toxicity | $38,300 |
| 2019 | Research Themes Investment Scheme Grant (RTIS), University of South Australia - Developing biomarkers and therapeutics for primary and metastatic lung cancer | $40,000 |
| 2019-2020 | NHMRC App 1161502 - A new direction in end of life care? Assessing the impact and outcomes of the Victorian Voluntary Assisted Dying Act | $1,210,399.80 |
| 2019-2020 | Envision Sciences Pty Ltd Translation Research Grant - Companion Diagnostics and therapeutics for cancer | $3,626,666 |
| 2019 | Health Translation SA Rapid Applied Research Translation for Health Impact Grant (MRFF) - Improving wait times between a positive faecal immunohistochemical test )+FIT) and diagnostic colonoscopy: <120 days for all. | $200,000 |
| 2018-2019 | UniSA Cancer Research Institute Strategic Funding Grant - Understanding the biology of lung cancer initiation and progression | $20,000 |
| 2018-2023 | NHMRC CRE - Targeted Approaches to Improve Cancer Services for Aboriginal and Torres Strait Islander Australians | $2,499,981 |
| 2018-2021 | Cancer Council SA Beat Cancer Project Clinical Trial Enhancement Grant APP ID #CTEG0617 | $400,000 |
| 2018 |
Cancer Council SA Beat Cancer Project Translational Research Package APP ID #TRP0717 - Supporting primary care to increase participation in bowel cancer screening: a pilot study |
$70,000 |
| 2018-2019 | ARC LIEF LE180100094 - Linked semantic platforms for social and physical infrastructure and wellbeing. (Administering university Swinburne University of Technology) | $1,361,651.00 |
| 2017-2022 | NHMRC Centres for Research Excellence Grant APP1135048. Centre for Research Excellence in Implementation Science in Oncology (CRE-ISO) | $2,495,783 |
| 2017-2018 | Envision Sciences Pty Ltd - Prostate cancer Diagnosis and Prognosis | $2,930,165 |
| 2017-2020 | NHMRC Partnership Grant APP1133407 - Investigating the inclusion of vulnerable populations in Advance Care Planning: Developing complex and sensitive public policy | $379,367.60 |
| 2017 | Beat Cancer Grant (CCSA and SAHMRI) App 1124968 - Improving the management of chemotherapy–induced nausea by assessing and treating nausea as a symptom cluster | $71,000 |
| 2017 | Research Themes Investment Scheme- Seed Funding. University of South Australia. - Exploring the challenges and decisions faced by children who need to manage the aged and end-of-life care of elderly | $38,480 |
| 2016-2017 | NHMRC Translational Research Projects for Improved Health Care Grant APP1133042 - Eradicating preventable deaths from colorectal cancer – the Beat Bowel Cancer Project | $100,000 |
| 2016-2017 | Research Themes Investment Scheme – Development Funding, University of South Australia -
Clonogenic Stem Cells in Head and Neck Cancer and Their Impact on Novel Treatment Approaches Based on Patient Stratification and Outcome Optimisation – Experimental and Modelling Investigation |
$26,288 |
| 2015-2017 | NHMRC Project Grant APP1080673 - Improving decisions about the funding of high cost cancer medicines in Australia | $549,492 |
| 2014-2016 | Cancer Australia Grant CA-ITA-1314/01 - Develop and disseminate resources to aid cancer survivors in successfully returning to work | $79,454 |
| 2014-2016 | NHMRC Project Grant. 1059732 - Addressing conflicts of interest in public health and biomedicine: enhancing professional integrity and safeguarding the public’s health | $564,553 |
| 2014-2016 | NHMRC Project Grant.1067062 - Should I take low-dose aspirin. The Optimise decision aid study | $424,115 |
| 2013-2015 | NHMRC Partnership Grant APP1059760 - Who decides and at what cost? | $247,653 |
| 2013-2014 | Sydney University Catalyst Grant - Development and phase 1 testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer | $50,000 |
| 2012-2013 | SAHMRI Grant - Development of a prototype, internet-delivered decision support tool for primary and secondary prevention of colorectal cancer | $60,000 |
| 2012-2015 | ARC Linkage Grant LP120200175 - Public and ethical responses to mandated alcohol warning labels about increased long term risk of cancer | $116,609 |
| 2012-2013 | Sydney Catalyst Grant - Should I take low dose aspirin? Development of the ‘Optimise’ decision aid for cancer chemoprophylaxis | $50,000 |
| 2011-2013 | NHMRC APP 1010536 - The role of individual patient, social support and treatment centre variables in the psychosocial outcomes of cancer patients | $ 494,604 |
| 2009-2011 | Cancer Australia Priority Driven Collaborative Cancer Research Grant ID 570961 - Understanding the psychosocial sequelae of surviving testicular cancer | $130,150 year 1 and 60,650 year 2 |
| 2009-2010 | International Program Development Fund University of Sydney - Building a cancer prevention partnership for women in Tamil Nadu, India – linking the Faculty of Medicine University of Sydney, Weill Cornell Medical College (USA), Cancer Council Australia & Christian Medical College Vellore, India | $55,000 |
| 2009 | MASCC Grant - Patients’ perceptions of chemotherapy induced nausea | $US 1000 |
| 2006-2007 | Commonwealth Govt RHSET grant - Enhancing palliation in patients with advanced cancer | $165,555 |
| 2006 | The Cancer Council SA - The effects of chemotherapy on cognitive function in patients with testicular cancer | $53,500 |
| 2006-2007 | The Cancer Council SA - Enhancing cancer Patients Participation when discussing clinical trial enrolment: Evaluation of a Question Prompt List 2006 | 2006 $36,300 2007 $36,300 |
| 2005-2006 | Australian Rotary Health Research Fund/ Rotary Club Adelaide - Mind body stress reduction to alleviate psycho-social distress post cancer treatment: A randomised controlled trial for patients diagnosed with lung cancer | $26,994 |
| 2006 | The Cancer Council SA - The Experience of the Patient Pathway by Patients of the Royal Adelaide Hospital Receiving Treatment for Cancer | $100,000 |
| 2005 | The Cancer Council SA - End of Life Decision-making Informing Policy Using “Maximum Variety” Sampling and Patient-Derived Qualitative Data | $68,342 |
| 2003 | The Cancer Council SA - Improving informed consent to chemotherapy: Written information versus an interactive CD-ROM | $47,800 |
| 2002-2003 | NHMRC - The Investigation of an Innovative Tele-medicine Model to Support Palliative Care Delivery in Rural and Remote Australia | $30,000 (2002, 2003) |
| 1999-2000 | NHMRC - Randomised trial of smoking cessation support for patients with cancer. | $50,583 (1999) $55,777 (2000) |
| 1999 | B3 Grant University of Adelaide. Patients’ Experience of Mucositis | $5,000 |
| 1999 | Anti-Cancer Foundation, South Australia - Anticancer active peptides from Australian Amphibians | $25,000 |
| 1998 | South Australian Health Commission - Pilot study of telemedicine to support home cancer treatment services | $39,000 |
| 1997 | University of Adelaide Research Fund - End of Life Decision Making | $5,000 |
| 1997 | NHMRC National Breast Cancer Centre Associated Centre Grant - | $100,000 |
| 1997 | Special Purpose Fund, Royal Adelaide Hospital - Combined modality therapy for locally advanced breast cancer | $10,000 |
| 1996 | NHMRC National Breast Cancer Centre Grant to establish and evaluate a telemedicine link between Royal Adelaide Hospital and Royal Darwin Hospital | $90,000 |
| 1996 | Faculty of Medicine Research Committee (University of Adelaide) - Cell Migration and its role in haemopoietic stem cell mobilisation | $10,000 |
| 1995-1996 | Anticancer Foundation Universities of South Australia - A phase II study of prolonged ambulatory infusion carboplatin and oral etoposide in patients with metastatic hormone resistant prostate cancer |
1995 $45,274 1996 $36,000 |
| 1991-1992 | NHMRC - Studies of prolonged ambulatory infusion anticancer chemotherapy | $70,000 |
| 1989-1991 | NHMRC -
Studies of drug radiation interactions in cancer |
$64,000 |
| 1988 | ACCV - Development of a murine model based on gastric distension to study the emetic and antiemetic potential of drugs (The Packenham Opportunity Shop Research Award, Ellen Margaret McBain Research Award, JB Rae Research Award, BS Robbins Nurseries Pty Ltd Research Award) | $25,000 |
| 1988-1989 | ACCV - Studies of high dose as an antiemetic for cancer chemotherapy induced emesis | $18,000 |
| 1987-1988 | ACCV - Phase I and II Evaluation of new anticancer drugs (McDougall Research Award) | $50,000 |
-
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2010 - 2014 Co-Supervisor Interpersonal factors impacting the decision to (continue to) use Complementary and Alternative Medicine (CAM) in men with cancer – a mixed-methods study Doctor of Philosophy Doctorate Full Time Ms Nadja Klafke 2010 - 2013 External Supervisor The psychosocial needs of rural cancer patients Master of Psychology (Clinical)/Doctor of Philosophy Doctorate Full Time Ms Kate Gunn 2005 - 2005 Other Radiotherapy for Bone Metastases and Neuropathic Bone Pain Doctor of Medicine Doctorate Full Time Prof Daniel Roos 2005 - 2008 Co-Supervisor The Family Meeting as an Instrument for the Spiritual Care of Palliative Patients and Their Families Doctor of Philosophy Doctorate Full Time Ms Heather Tan 2005 - 2008 Co-Supervisor Developing Strategies to Improve the Management of Chronic Illness Doctor of Philosophy Doctorate Full Time Dr Vikki Knott 2005 - 2011 External Supervisor The Psychoneuroimmunology of Women Experiencing Stressful Life Events:Testing the Oxidative Model Doctor of Philosophy Doctorate Part Time Dr Jodie Merle Oliver-Baxter 2004 - 2010 Principal Supervisor Enhancing knowledge: the impact of experience and information Master of Medical Science Master Full Time Miss Hedyeh Hedayati 1999 - 2006 Principal Supervisor The Do-Not-Resuscitate Decision: A Discursive Analysis Of Cancer Patients' Talk Doctor of Philosophy Doctorate Part Time APrf Jaklin Eliott
-
Board Memberships
Date Role Board name Institution name Country 2019 - ongoing Chair Board of the Sax Institute Sax Institute Australia 2014 - 2018 President MASCC Board MASCC (Multinational Association for Supportive Care in Cancer) Australia 2013 - 2015 Board Member COSA Board of Directors Clinical Oncology Society of Australia Australia 2012 - 2018 Council Council National Health and Medical Research Council Australia 2012 - 2014 Treasurer MASCC Board MASCC (Multinational Association for Supportive Care in Cancer) Australia 2010 - ongoing Board Member MASCC Board MASCC (Multinational Association for Supportive Care in Cancer) Australia -
Committee Memberships
Date Role Committee Institution Country 2019 - ongoing Chair Scientific Committee GIN and JBI Conference Adelaide Guidelines International Network Australia 2019 - ongoing Chair Youth Cancer Services Strategic Advisory Committee Canteen Australia 2018 - ongoing Chair Program Committee 3rd Global Adolescent and Young Adult Cancer Congress Canteen Australia 2017 - ongoing Co-Chair SA Aboriginal Chronic Disease Consortium Cancer Committee SA Aboriginal Chronic Disease Consortium Cancer Australia 2017 - ongoing Chair Data Safety Monitoring Board for BEAMS (Breathlessness, Exertion and Morphine Sulphate Trial) Palliative Care Clinical Studies Collaborative Australia 2017 - ongoing Chair Adelaide Biomed City Research Advisory Committee Adelaide Biomed City Australia 2017 - 2019 Member Adelaide Biomed City Partners Committee Adelaide Biomed City Partners Australia 2017 - 2018 Member Priority Driven Research Grants - Reviewer Cancer Australia Australia 2017 - 2018 Member SA-NT Datalink Steering Committee SA-NT Datalink Australia 2017 - ongoing Advisory Board Member SA Health Statewide Research Advisory Group SA Health Statewide Australia 2016 - ongoing Member Translational Research Centre Beat Bowel Cancer Project Committee Translational Research Centre Beat Bowel Cancer Project Australia 2016 - ongoing Chair Cancer Australia Statements – Influencing Best Practice in Cancer, Steering Group Cancer Australia Australia 2016 - 2018 Board Member Organising Committee ASCO Palliative and Supportive Care Symposium United States 2016 - ongoing President MASCC Committee Multinational Association of Supportive Care in Cancer Australia 2016 - ongoing Chair Venture Grants Committee Cancer Council Victoria Australia 2015 - 2019 Member SA Academic and Translational Research Centre Executive Committee SA Academic and Translational Research Centre Executive Australia 2015 - 2018 Member The Implementation and Evaluation Subcommittee The SA Academic and Translational Research Centre Australia 2015 - ongoing Member South Australian Committee Friends of Vellore Australia 2015 - 2018 Board Member ASCO Foundation International Innovation Grants Committee American Society of Clinical Oncology United States 2015 - ongoing Chair SA Health Cancer Drug Committee SA Health Cancer Australia 2014 - ongoing Member Youth Cancer Services Strategic Advisory Committee Canteen Australia 2014 - ongoing Member Research Advisory Committee Movember Australia 2013 - 2015 Member AHEC/HGAC (Human Genetics Advisory Group) Guidelines Subgroup National Health and Medical Research Council Australia 2013 - ongoing Chair Expert Advisory Group: Ethical Guidelines – Organ Transplantation National Health and Medical Research Council Australia 2012 - 2018 Chair Australian Health Ethics Committee National Health and Medical Research Council Australia 2012 - 2017 Chair Assisted Reproduction Technology Group National Health and Medical Research Council Australia 2012 - 2015 Board Member International Affairs Committee American Society of Clinical Oncology United States 2012 - 2014 Treasurer MASCC Committee Multinational Association of Supportive Care in Cancer Australia 2009 - 2017 Member Xenotransplantation Guidelines Group National Health and Medical Research Council Australia 2009 - 2013 Member Australian Health Ethics Committee National Health and Medical Research Council Australia 2008 - 2015 Member Palliative Care Working Group European Society of Medical Oncology Switzerland 2007 - ongoing Chair Medical Oncology Group of Australia Ethics Committee Medical Oncology Group of Australia Australia 2006 - 2015 Advisory Board Member Cancer Australia Advisory Board Cancer Australia Australia 2005 - ongoing Chair Ethics Committee Medical Oncology Group Australia Australia -
Consulting/Advisories
Date Institution Department Organisation Type Country 2019 - ongoing Aucentra Therapeutics Pty Ltd Aucentra Therapeutics Advisory Board Health services and related Australia 2019 - ongoing Australian Research Council Australian Research Council Medical Research Advisory Group Scientific research Australia 2019 - ongoing VieCure VieCure Clinical Advisory Committee Health services and related United States 2019 - ongoing Bellberry Limited Bellberry Ethics Committee Health services and related Australia -
Editorial Boards
Date Role Editorial Board Name Institution Country 2018 - ongoing Editor-In-chief Editorial Board Journal of Supportive Care in Cancer Australia -
Review, Assessment, Editorial and Advice
Date Title Type Institution Country 2015 - ongoing Medical Journal of Australia Advisory Board Advice Medical Journal of Australia Australia 2015 - ongoing European Journal of Cancer Care Board Journal Review European Journal of Cancer Care Australia 2010 - ongoing Cancer Monitoring Advisory Group Advice Commonwealth Department of Health and Aging Australia
Connect With Me
External Profiles
